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A NOTE FROM ROSS HALL 
t has been said that the most important 
thing that we do as a university is cre-
ate alumni who graduate with their new 
knowledge and skills prepared to make a 
difference in the world. 
The GW School of Medicine and Health 
Sciences (SMHS) has generated thousands of 
outstanding and influential physicians, health 
professionals, and scientists who have touched 
millions of lives and thousands of communities. 
Over the past several months, I have been 
honored to meet with our Medicine and Health 
Sciences alumni in multiple cities across the 
country. Without question, the most common 
thing I hear from our alumni is that they believe 
they were better prepared than their non-GW 
peers as they embarked upon their health careers. 
Our alumni are remarkably proud of GW and 
grateful for the education, training, and opportu-
nities afforded to them.
SMHS alumni are eager to rattle off 
the names of their classmates who are 
accomplishing great things. Our alumni are 
internationally recognized for their cutting-
edge basic science and clinical research, their 
advanced clinical practices, their leadership 
in professional and scientific societies, their 
service to their communities and commitment 
to philanthropy, and their reputations 
as distinguished physicians and health 
professionals. 
Our alumni have discovered new treatments 
and medical devices, made important 
contributions to medical and scientific literature, 
influenced legislation and health policy, and 
led complex organizations. They are a valuable 
resource for the communities in which they 
live and work, for each other, as well as for our 
current and future students. 
These achievements and contributions are 
central to the overall reputation of SMHS. 
We look to our alumni to serve as a built-in 
community of outstanding role models and 
mentors for our students. We also ask our 
alumni to contribute to the advancement of our 
school and society.
Please email (smhsalumni@email.gwu.edu) 
and keep us informed of your current projects, 
employment, appointments, and latest accom-
plishments. Your classmates, the GW medical 
community, and I want to hear about the great 
things you are doing. 
Best wishes,
JEFFREY S. AKMAN, M.D. ’81, G.M.E. ’85
INTERIM VICE PRESIDENT FOR HEALTH AFFAIRS 
AND DEAN, SCHOOL OF MEDICINE  
AND HEALTH SCIENCES
Building a Community 
of Knowledge and Skill
I
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Raphael Karkowsky, a fourth-year medical student in the George Washington 
University School of Medicine and Health Sciences (SMHS), wasn’t sure if it 
was nerves or just a sugar rush from brunch. Whatever it was, he knew his 
heartbeat was picking up its pace. 
Like thousands of other fourth-year medical students across the country, 
including his twin brother at the University of Maryland School of Medicine, 
Karkowski was anticipating what many call the most pivotal moment of their 
medical education: Match Day.
Held on March 16 this year, nearly 16,000 medical students nationwide 
simultaneously received and opened envelopes from the National Residency 
Matching Program revealing the institution where they will be spending at least 
the next three years of their professional lives. At GW, students, faculty, family, 
and friends all gathered in Ross Hall to celebrate the occasion.
“You matched at some incredible places across the United States of America 
— including the George Washington University,” said Yolanda Haywood, M.D., 
assistant dean for Student and Curricular Affairs and associate professor of 
Emergency Medicine at SMHS, at the ceremony.
When the clock struck noon, the students — who were dressed in t-shirts 
and accessories signifying their intended specialty — tore into their envelopes. 
Cheers, tears, and champagne toasts ensued.
Across the room, Karkowsky, who matched to an internal medicine residency 
at Thomas Jefferson University, tried to reach his twin brother William. “I’m 
really happy,” he said. His brother matched in internal medicine at the University 
of Chicago.
Overall, SMHS students matched with many of the leading institutions 
across the country, including Einstein/Beth Israel Medical Center in New York 
City, the University of Chicago Medical Center, Massachusetts General Hospital 
in Boston, and the Baylor College of Medicine in Houston. Fourteen students 
will continue their training here at GW.
To see the complete list of this year’s SMHS Match Day schools, visit  
www.gwumc.edu/matchday2012.  n
MAKING THE ROUNDS
Rather than spending the day before 
residency Match Day pacing, nail-bit-
ing, and going over last-minute “what-
if” scenarios, a group of fourth-year 
GW medical students redirected that 
pre-match nervous energy back into 
the community.
More than 60 budding physi-
cians helped to renovate what might 
become a safe house for Washing-
ton, D.C. residents in need, during 
the Gold Humanism Honor Society’s 
(GHHS) Annual Day of Service, on 
March 15.
“Each year, GHHS members vote 
on how they’d like to spend their day 
of service,” explained Rahul Vanjani, a 
GHHS member. “This year, we chose 
something that we believed character-
ized our class and the type of project 
we wanted to pursue: a focus on the 
underserved and the integration of 
GW into the D.C. community.”  
The event, organized by GHHS 
and open to all fourth-year medical 
students, linked GW students with 
Temporary Emergency Residential 
Resource Institute for Families in 
Crisis (TERRIFIC, Inc.), a non-profit 
housing and human service organi-
zation serving families in crisis. GW 
volunteers spent the day painting the 
interior of a three-story house as part 
of a renovation project.
A highlight of the day, according to 
Joanie Brumbaugh, a GHHS member 
and Day of Service organizer, came 
when the founder of TERRIFIC, Inc. 
visited the GW team on site. “She was 
moved to tears and thanked us for 
providing a service that her organi-
zation couldn’t afford,” said Brum-
baugh. “She was so excited about the 
potential of that house to be a place 
of refuge and hope.”  n
Match Madness
A Day of Service
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While her classmates were anx-
iously waiting during the Match Day 
countdown March 17, Elizabeth 
Wiley, J.D., M.P.H., a fourth-year 
medical student at the George 
Washington University School of 
Medicine and Health Sciences 
(SMHS), was touring Ghana, where 
she served as a delegate at the 61st 
General Assembly March Meeting 
of the International Federation of 
Medical Students’ Associations. 
But Wiley was just as nervous 
as her peers back in the United 
States. She too was awaiting big 
news about her future, specifi-
cally, whether or not she had been 
elected to serve as the national president of the American Medical Student 
Association (AMSA), the nation’s oldest and largest independent association for 
physicians-in-training.
“When the election results were 
announced, I was elated — and 
relieved!” said Wiley, who will delay 
residency for a year during her term 
as president. “It’s an honor to lead an 
exceptional organization that inspires 
a community of future physicians 
through education and advocacy.” 
Wiley is the first GW student to 
hold this position — a full-time job 
that involves chairing AMSA’s Board 
of Trustees, maintaining alliances with 
other organizations, and visiting AMSA chapters around the country — but it’s 
GW that Wiley credits for priming her for the responsibility. 
“Throughout medical school, I’ve had unparalleled opportunities to integrate 
my passion for health policy and advocacy into my training,” she said. Through 
SMHS’s track in Health Policy, Wiley even worked with professors Fitzhugh Mul-
lan, M.D., M.P.H., Murdock Head Professor of Medicine and Health Policy, and 
Candice Chen, M.D., M.P.H., assistant research professor of Health Policy, in 
GW’s School of Public Health and Health Services, to draft legislative language 
that ended up in the Patient Protection and Affordable Care Act. 
“I don’t think any other medical student in the country is able to say that,” 
said Wiley. “And it’s thanks to GW that I had that opportunity.” 
Throughout her term, Wiley hopes to advocate for increased access to health 
care for all Americans, address the growing problem of student debt, and bring 
more political awareness to HIV/AIDS and reproductive justice. 
“I want to be a voice for medical students in the upcoming election and on 
Capitol Hill,” she said.  n
A Voice for Medical Students 
“Throughout medical school, 
I’ve had unparalleled 
opportunities to integrate my 
passion for health policy and 
advocacy into my training.”
Elizabeth Wiley, J.D., M.P.H
Already one of the largest robotic 
surgery programs in the country, 
the George Washington University 
Hospital (GW Hospital) is taking steps 
to become the regional leader among 
multi-specialty robotic observation 
centers. With the addition of two new 
robots, GW Hospital is the first in the 
Washington/Baltimore area offering 
daVinci Si robots with dual console ca-
pability and fluorescence imaging and 
skills simulation for surgical training. 
Paired with the dual console sys-
tem, two surgeons are able to collabo-
rate during a procedure and exchange 
control of the instrument arms and 
endoscope. The console also features 
built-in intercoms to facilitate commu-
nications between surgeons while both 
are seated at consoles. 
“The advantages of robot-assisted 
surgery are significant,” says Thomas 
W. Jarrett, professor of Urology at the 
School of Medicine and Health Sci-
ences, and chair of the Department 
of Urology at the GW Medical Faculty 
Associates. “Incisions are smaller, 
patients may experience less pain, 
they often do not need strong narcotic 
pain medication, and they can resume 
their normal daily activities in about 
half the time as they can with tradi-
tional surgery.” 
In 2004, GW Hospital became the 
first in the area to have the daVinci 
system. Since then, GW surgeons 
have performed more than 2,500 
robotic procedures. GW’s surgical 
team was the first in the area to use 
the daVinci for colectomies, and in 
January, Fredrick Brody, M.D., director 
of Minimally Invasive Surgery, and Paul 
Lin, M.D., vice chair of the Department 
of Surgery and Chief of General and 
Hepatopancreatic Surgery, performed 
the region’s first robotic-assisted lapa-
roscopic Whipple procedure. n
The Marriage of  
Medicine and Machine
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will be constructed on the northwest 
side of the building to provide better 
access inside Ross Hall and an addi-
tional route out of the building. The 
project will be managed by GW and 
facilitated in close collaboration with 
the NIH to meet the requirements of 
ARRA funding. Clark Construction 
will implement the work. The project 
will begin in May 2012 and is slated for 
completion in the fall of 2013. 
Concurrent with the Research 
Center for Neglected Diseases project 
there will be upgrades to the Ross Hall 
central utility plant (CUP). Renova-
tions to the CUP will support Ross Hall 
infrastructure as well as provide utilities 
for the Science and Engineering Hall.
For more information about the 
Ross Hall construction project, visit  
www.gwumc.edu/ 
rosshallconstruction. n 
MAKING THE ROUNDS
Facilities Improvement to  
Build a Route Out of Poverty
At the core of the mission of GW’s School of Medicine and Health Sciences 
(SMHS), faculty and physicians strive to improve the health and well-being of 
the local, national, and global communities. With the aide of a $15 million grant 
awarded to SMHS from the National Institutes of Health (NIH) through the 
American Recovery and Reinvestment Act (ARRA), as well as additional support 
from the school, GW is embracing this ideal and building a new research center to 
address Neglected Diseases of Poverty. These diseases, which include Neglected 
Infections of Poverty and Neglected Tropical Diseases, are illnesses prevalent 
among the world’s poorest and most desperate populations, affecting billions of 
people, especially children. Often these populations are left too sick to work or go 
to school — contributing to a perpetual cycle of poverty.
GW’s new Research Center for Neglected Diseases of Poverty will be equipped 
with state-of-the-art laboratories where researchers will be empowered to identify 
innovative ways to focus on prevention and treatments for people who are afflicted 
with these diseases. GW’s biotechnology capacity will expand through new equip-
ment and increased efficiencies within the lab space, creating more collaborative 
learning spaces for students, laboratory personnel, and faculty. Additional research 
will be conducted at the facility to translate basic science discoveries into new prod-
ucts. The Center will provide the space and facilities to enable SMHS to recruit 
new faculty and staff and expand the mission of the Center. 
To accommodate the new center, the fifth and sixth floors of Ross Hall will be 
fully renovated to provide new laboratory space and an exterior-egress stairwell 
An architectural rendering of the new interior space of Ross Hall. 
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There aren’t many researchers in the world who can call 
themselves experts on Thymosins. The small, naturally 
occurring proteins that hold diverse biological roles includ-
ing the stimulation or suppression of the body’s immune 
response were first identified more than 40 years ago, but 
only now are their powers being fully explored. But among 
the world’s leading scientists investigating thymosins, most 
were on GW’s campus for the Third International Sympo-
sium on Thymosins in Health and Disease, March 14–16. 
Researchers from Europe, Asia, and North America pre-
sented their work on the impact of two thymosins, α1 and 
β4, on cardiovascular disease; neurodegenerative diseases 
and brain trauma; wound healing; immunomodulation, 
infectious diseases, and tolerance; cancer; and vaccines.
The symposium was co-hosted by Allan Goldstein, 
Ph.D., professor and Chair Emeritus, of GW’s School of 
Medicine and Health Sciences Department of Biochemistry 
and Molecular Biology, and Enrico Garaci, M.D., president 
of the Instituto Superiore di Sanita and professor of Micro-
biology at the University of Rome “Tor Vergata.” 
More than just responsible for launching the internation-
al conference, the pair are considered founding members 
of the select community of thymosin researchers. In the 
mid-1960s, Goldstein discovered thymosins, first isolating 
the hormone-like peptides.
Since then, a synthetic version, Thymosin α1, has been 
tested in lung cancer patients, used in treatments for hepa-
titis B and C, and used as therapy to boost immune system 
responses in patients around the world. 
“We still need to define the full therapeutic potential of 
these thymic peptides and to further define the physiologi-
cal role of the thymus in health and disease,” explained 
Goldstein.
The three-day conference culminated with the presen-
tation of the 2012 Abraham White Scientific, Humanitarian, 
and Public Service Awards, honoring three individuals for 
their unique contributions to science, medicine, and the 
global community: Deepak Srivastava, M.D., professor of 
Pediatrics and director of the Gladstone Institute of Cardio-
vascular Disease; Luigina Romani, M.D., Ph.D., professor 
of Microbiology at the University of Perugia, Perugia, Italy; 
and Margaret Stern, chair of The Michael Stern Parkinson’s 
Research Foundation, who received the award on behalf of 
her father, Michael.  n
GW Symposium Attracts Global  
Experts in Thymosins Research 
Rakesh Kumar, Ph.D., Catharine Birch 
and William McCormick Chair of the 
department of Biochemistry and Mo-
lecular Biology in the George Wash-
ington University’s School of Medicine 
and Health Sciences (SMHS), says the 
aim of his department’s Nobel Laure-
ate lecture series “is to bring the best 
people in the world to Washington, 
D.C., and to GW.”
That lofty goal was achieved in 
February, when Nobel Laureate Aaron 
Ciechanover, M.D., Ph.D., traveled 
from his home in Israel to GW’s Foggy 
Bottom campus to deliver the depart-
ment’s second Nobel Laureate lecture.
Ciechanover won the Nobel Prize 
in Chemistry in 2004 with two other 
scientists for describing how proteins 
are broken down by cell enzymes. 
During his lecture, Ciechanover 
recalled the road to his discovery. 
When he first started out, he said, 
“people were mesmerized by tran-
scription,” the process by which DNA 
is converted to RNA. “People didn’t 
care about destruction. They were 
fascinated with construction.”
But Ciechanover wasn’t like most 
people. He was interested in destruc-
tion, in particular, the degradation of 
proteins in cells. “We are replacing 
every molecule in our body, and yet, 
we remain the same,” he marveled.   
Intracellular protein degradation is 
important for “quality control” issues, 
Ciechanover explained. In the same 
way that meat in the refrigerator goes 
bad, the quality of the protein in our 
cells diminishes over time. The body 
has highly specific processes to 
replace the poor quality proteins with 
fresher ones. If these processes are 
imperfect, it can cause diseases such 
as cystic fibrosis.
Ciechanover questioned the 
growing emphasis on translational 
research, moving basic science dis-
coveries into therapeutics. Although 
his discovery has since led to the 
development of drug therapies, such 
as those used to treat neurodegenera-
tive disorders, Ciechanover said his 
goal was never therapy-driven. 
“The whole thing evolved out of a 
curiosity to answer an unanswered 
biological question — not to develop 
any drug,” he said. “I think it’s a les-
son. It shows you that curiosity leads 
you to unexpected growth at the  
end.” n
From Curiosity to Cure 
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From the diagnosis of acute upper 
gastrointestinal hemorrhage to the 
epidemiology of dengue fever in St. 
Lucia, students, faculty, and residents 
in GW’s School of Medicine and 
Health Sciences tackle not only the 
most academically interesting subjects 
in health care, but also the topics with 
the greatest influence on the health and 
well-being of people around the world.  
These projects and more than 300 
others were on display at GW’s 17th 
Annual Health and Medicine Research 
Day, March 28.
“Health and Medicine Research 
Day is always an exciting day,” said 
Jeff Akman, M.D., ’81, G.M.E. ’85, 
interim vice president for Health Affairs 
and dean of SMHS, who delivered 
welcoming remarks at the Jack Morton 
special skills that really are encom-
passed across the spectrum of our 
enterprise.”
During her speech, 
Guay-Woodford, a 
pediatric nephrolo-
gist, described recent 
scientific advances 
in polycystic kidney 
disease and used 
the condition as an 
allegory for successful 
translational research.
Fifty percent 
of patients with 
polycystic kidney 
disease, a genetic 
kidney disorder, progress to end-stage 
renal disease, said Guay-Woodford. 
One of the goals of her research is to 
understand why the other half doesn’t 
progress and then to use that knowledge 
to help prevent disease progression in 
all patients.
“We are getting close to targeted 
therapies that will weaken the progres-
sion of the disease,” she said. “If we 
could change the natural history of the 
disease so that no one suffers end-stage 
renal disease, that would be a major 
clinical advance.”  
Translating Research to the Community
In the afternoon, the spotlight 
turned from experienced researchers 
to aspiring ones, as students presented 
their projects on posters that filled 
the Marvin Center. They shared what 
they’ve learned with each other and 
responded to rapid questioning from 
faculty members who judged their work. 
At the award ceremony that 
followed, winners of the oral competi-
tion delivered short presentations about 
their research. Rakesh Kumar, Ph.D., 
professor and Catharine Birch and 
William McCormick Chair of SMHS’s 
Department of Biochemistry, and 
Jeanny Aragon-Ching, M.D., assistant 
professor in SMHS’s Department of 
Medicine and a member of the Division 
of Hematology and Oncology at The 
GW Medical Faculty Associates, were 
awarded the 2011 Elaine H. Snyder 
Cancer Research Award. John N. van 
den Anker, M.D., Ph.D., professor of 
Pediatrics and of Pharmacology and 
Physiology at SMHS received the 2012 
Distinguished Researcher Award  
(see p. 34).
For a complete list of the winners of 
the oral competition and poster presen-
tations, visit www.gwumc.edu/ 
researchday2012.  n
“Translational research knits us together as 
a research community, because translational 
research is a team sport and it requires 
people with special skills that really are 
encompassed across the spectrum of our 
enterprise.” 
Lisa Guay-Woodford, M.D.
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Following her GW Research Day address, Lisa Guay-Woodford, M.D., director of the 
Clinical and Translational Science Institute at Children’s National Medical Center, at right, 
toured the poster session area.
Auditorium. “It enables us to truly 
learn about the expanding scientific 
enterprise that’s happening right here 
within our own institution.”
The annual event kicked off with a 
keynote address delivered by Lisa Guay-
Woodford, M.D., director of the Clini-
cal and Translational Science Institute 
at Children’s National Medical Center 
(see p. 7).
“Translational research knits us 
together as a research community,” she 
said, “because translational research is 
a team sport and it requires people with 
MAKING THE ROUNDS
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Researchers in GW’s School of Medicine and Health Sciences (SMHS) 
Department of Biochemistry and Molecular Biology, published a 
first-of-its-kind study into the use of mRNA sequencing to look at 
the expression of the genome for three types of breast cancer at an 
unprecedented resolution. The study, titled “Transcriptomic landscape 
of breast cancer through mRNA sequencing,” was published in the 
Feb. 14 edition of the journal Scientific Reports, a new open access 
journal from the publishers of Nature for large-volume data. 
Breast cancer is the leading cause of cancer death among women, 
accounting for about 23 percent of the total cancer cases and about 
14 percent of the cancer deaths worldwide. An obstacle hindering 
the translation of gene expression research into patient treatments is 
the highly individualized nature of the disease. One avenue past this 
roadblock is gaining a deeper insight into the transcriptional regulatory 
machinery responsible for the cellular changes that result in breast 
cancer. 
The GW team, led by senior author Rakesh Kumar, Ph.D., GW’s 
Catharine Birch and William McCormick Chair of the department of 
Biochemistry and Molecular Biology, contrasted the gene expres-
sion patterns of 17 patients with three different types of breast cancer 
to identify biologically relevant, therapeutically important, targets in 
breast cancer. The researchers defined a comprehensive digital tran-
scriptome — RNA molecules found in a population of cells — and per-
formed extensive comparative analysis of the three groups of breast 
cancer. Their research yielded a staggering 1.2 billion reads at various 
levels of the transcriptional process.  
“For the first time, mRNA sequencing of human breast cancer 
tissues provides knowledge on central transcriptional regulatory ele-
ments, demonstrating unexplored niches that could change the way 
breast cancer is understood,” said lead author Jeyanthy Eswaran, 
Ph.D., director of GW’s McCormick Genomic and Proteomic Center. 
While most research today is focused on preselected genes, the 
GW team used an unbiased approach to come up with an original 
snapshot of the breast cancer transcriptome. The team is working to 
gain a better understanding of the fundamental occurrences orches-
trating the events that lead to a patient suffering from breast cancer. 
“From the ongoing work in the laboratory, it is clear that this study 
has implications beyond the current digital transcriptome of breast 
cancer, as the team is actively characterizing novel mutations in pro-
tein-coding genes and other elements of human genome that might be 
relevant in breast cancer,” said Kumar. The work, he said, may influ-
ence breast cancer genomics, the transcriptional regulation of cancer, 
and help build new biologic pathways in breast cancer.
For more information about ongoing research in the Department of 
Biochemistry and Molecular Biology, visit gwumc.edu/smhs/ 
biochemistry/support.html.  n
Digital Transcriptome Discovery Could Lead  
to Targeted Therapies for Breast Cancer
New Leaders  
in GW Medicine
The George Washington University School of 
Medicine and Health Sciences and its partnering 
institutions the George Washington University 
Hospital (GW Hospital) and Children’s National 
Medical Center (Children’s National), recently 
added key new personnel to their executive 
teams. 
Lisa Guay-Woodford, M.D., Ph.D., joined 
Children’s National as the new director of the 
Center for Clinical and Community Research 
and the Principal Investigator of the Clinical and 
Translational Science Institute (CTSI). Trained 
and certified as a pediatric nephrologist, Guay-
Woodford will lead the CTSI’s mission to speed 
the development of new treatments by making 
it easier for basic science discoveries to move 
from the laboratory to clinical care. The CTSI 
was formed out of a five-year, $20 million Clinical 
and Translational Science Award (CTSA) from 
the National Institutes of Health. Guay-Woodford 
comes to Children’s National from the University 
of Alabama at Birmingham (UAB) where she was 
the principal investigator of UAB’s CTSA.
GW Alumnus Barry A. Wolfman, M.S. ’84, 
recently joined GW Hospital to serve as CEO 
and Managing Director. In his 27-year career 
in health care, Wolfman has served as a multi-
system senior executive, hospital CEO, and 
medical school board member. His most recent 
position was with Providence Health & Services 
as chief executive at Providence Saint Joseph 
Medical Center in Burbank, Calif. 
Dennis Narango was selected as associate 
dean of the School of Medicine and Health 
Sciences (SMHS) and associate vice president 
of GW Medicine Development and Alumni 
Relations. In his role, Narango leads the 
development and alumni affairs team in support 
of SMHS and directs all aspects of fundraising 
and capital development for GW Medicine. He 
comes to GW from the University of Maryland 
School of Medicine where he was the associate 
dean for development and chief development 
officer.  n
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There’s no good reason to fear old age, says Beverly Lun-
sford, Ph.D., R.N., director of the Center for Aging Health 
and Humanities in GW’s School of Medicine and Health 
Sciences (SMHS), and associate research professor in the 
George Washington University School of Nursing (SON). 
Older adults live active and vibrant lives, she says. They 
continue to grow, develop, and seek meaning and purpose 
in their lives. They are not the sum of their broken parts; 
they are individuals with potential — and they deserve to be 
treated as such. 
“I want to change people’s notion of the older adult from 
someone who’s just a health problem to a person with cre-
ative potential,” says Lunsford. And thanks to a three-year, 
$500,000 grant from the Health Resources and Services 
Administration (HRSA), she is already working toward this 
goal. 
The award, which is in the final year of its original fund-
ing, supports the Geriatric Education Utilizing a Palliative 
Care Framework (GEPaC) project, a multi-disciplinary effort 
aimed at increasing access to high-quality geriatric educa-
tion for physicians, nurses, occupational and physical thera-
pists, physician assistants, and other clinicians who provide 
care for the over-65 crowd — a population that’s growing by 
the second.
“There are gaps between geriatric and palliative care 
education,” says Lunsford. But because most people over 
the age of 65 are dealing with chronic health conditions, 
closing those gaps is more critical than ever before. 
Faculty Integrate 
Palliative Care into 
Geriatrics Education 
“The goal is to achieve quality of life that gives 
the person the opportunity to continue to grow 
and develop as a person.”
Beverly Lunsford, Ph.D., R.N.
Through the GEPaC curriculum, aspiring health care 
professionals will learn how to manage disease in a way that 
promotes optimal functioning and a high quality of life. The 
modules focus on person-centered care, communication, 
interdisciplinary collaboration, quality of life, and multi-
dimensional aspects of aging. 
“The goal is not curing,” says Lunsford. “The goal is to 
achieve quality of life that gives the person the opportunity 
to continue to grow and develop as a person.”
Lunsford credits her interdisciplinary team of colleagues 
— including Philip Blatt, P.T., Ph.D., assistant professor 
of Health Care Sciences at SMHS; Cheryl Arenella M.D., 
M.P.H, a cancer education specialist in Virginia; Jacqueline 
Barnett, M.S.H.S., P.A.-C., assistant professor of Health 
Care Sciences; Elizabeth Cobbs, M.D., associate profes-
sor of Medicine at SMHS; Mary Corcoran, Ph.D., associate 
dean of Faculty Development for Health Care Sciences at 
SMHS; Jean Johnson, Ph.D., R.N., dean of SON; Laurie 
Lyons, instructional designer at SMHS; Laurie Posey, Ed.D., 
assistant professor at SON; and Paul Tschudi, Ed.S., visiting 
assistant professor of Health Care Sciences at SMHS — 
with helping make the project accessible to a wide variety of 
health professions
Once complete, the collaboration between SON, SMHS, 
Shenandoah University, and the National Hospice and 
Palliative Care Organization will implement the project in tra-
ditional classroom, online classroom, and online continuing 
education settings. 
“There is a real hunger for geriatrics education,” says 
Lunsford. “If we can teach it from a palliative perspective, 
we can better manage disease, improve quality of life, sup-
port the patient and family, and lower health care costs. It’s 
a win-win situation.”  n
MAKING THE ROUNDS
 M E D I C I N E  +  H E A LT H        98   smhs.gwumc.edu    •    S P R I N G  2 0 1 2
Two years of basic sciences, two years of clinical rotations. That’s the standard 
medical education curriculum, a formula that’s been in place for decades in 
many American medical schools. But just because that’s the way it’s always 
been that way doesn’t mean it’s the way it should be, say members of the New 
Curriculum Committee at George Washington University School of Medicine 
and Health Sciences (SMHS) .
The group, an ad hoc committee of the school’s Curriculum Oversight 
Group, is taking a close look at the medical education curriculum at SMHS, 
as well as the curriculum at other medical schools. Based on the committee’s 
feedback and recommendations, a new curriculum will be developed and is on 
track to be implemented in fall 2014. 
“Educating our students to serve as clinicians, researchers, and health policy 
leaders is a sacred trust,” says Alex Stagnaro-Green, M.D., senior associate 
dean for Education at SMHS and chair of the committee. “The process we are 
undertaking is both exciting and daunting.”
The New Curriculum Committee, which has held weekly meetings since 
February 2011, comprises medical students, department chairs, residency 
directors, course and clerkship directors, and others. Ensuring accurate repre-
sentation was a top priority when forming the group, says Stagnaro-Green. 
A Medical Education Makeover 
NEW CURRICULUM REVAMP EMPHASIZES PATIENT CARE
“We want to make certain that it’s 
a school-wide effort that people feel 
excited about and vested in because 
they were active participants in its 
creation,” he says. 
According to Thomas “Bruce” 
Shaver, a third-year medical student at 
SMHS who serves on the committee, 
the approach is working. “The open-
ness and inclusiveness of the process 
has strengthened my belief that SMHS 
really is a special place, and I am very 
excited about the changes that are 
forthcoming,” he says. 
One of the committee’s first tasks 
was to identify the guiding principles 
that would provide a framework 
for the process. They decided on 
concepts that include professional 
growth, taking responsibility, and early 
clinical exposure. In all, the eight prin-
ciples form the acronym PATIENTS. 
“One of the hallmarks of GW is that 
we train great clinicians,” says Stagn-
aro-Green. “The acronym PATIENTS 
is emblematic of our commitment to 
developing a curriculum that puts the 
patient first.” 
But the committee is not afraid to 
look to other schools for curricular 
inspiration. They have visited universi-
ties both near and far, including The 
Johns Hopkins University School of 
Medicine, The New York University 
School of Medicine, and the Paul L. 
Foster School of Medicine (PLFSOM) 
in El Paso. Stagnaro-Green calls PLF-
SOM a “fascinating” model that uses 
a symptom-based, not the traditional 
systems-based, integrated curriculum. 
Rather than mimicking any of the 
other models, the new curriculum will 
likely feature elements of many. The 
ultimate goal, says Stagnaro-Green, is 
to create the best possible curriculum 
for the next generation of GW-trained 
physicians. “The new curriculum pro-
cess will serve to maintain GW as a 
national leader in medical education,” 
he says.  n
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Custom Tailoring
t wasn’t long ago when the idea of tailoring drug 
therapy based on a patient’s genetic makeup, or 
distinguishing which drug might be most effective in 
battling a person’s cancer would be relegated to the 
pages of a science fiction novel. But today, it’s called 
science. Real science. Pharmacogenomics (PGx) to be 
exact. The marriage of pharmacology and genetics 
is a union that spawns research aimed at personalizing drug 
therapies and being able to predict drug responses based on a 
patient’s genetic makeup.
In addition to reducing life-threatening adverse reactions 
to drugs, genetic testing itself may also be predictive of treat-
ment failure or success. “All medications will be designer 
drugs someday,” said Travis O’Brien, Ph.D., director of the 
Pharmacogenomics program and associate research professor 
of Pharmacology and Physiology in GW’s School of Medicine 
and Health Sciences (SMHS). “PGx will be another tool in 
the armamentarium in battling disease.”
In 2005, in conjunction with Shenandoah University’s 
Bernard J. Dunn School of Pharmacy, SMHS began offer-
ing the nation’s first bachelor’s degree in PGx. Courses are 
primarily held at the GW campus in Ashburn, Va., and can 
lead to either a bachelor’s degree in Health Science (B.S.H.S.) 
in Pharmacogenomics or a B.S.H.S./Doctor of Pharmacy 
(Pharm.D.) dual degree.
O’Brien said the goal of the program is to educate a new 
generation of Health Sciences graduates “who are acutely 
aware of the interface between human genetic variability 
and drug action, as well as the role that genomics can play in 
identifying biomarkers for disease and targets for therapy.”
Students in the program participate in the groundbreaking 
research led by O’Brien, who received his doctorate in Toxi-
cology from the University of Cincinnati College of Medicine. 
One study looks at the drug Warfarin, an oral anticoagulant 
typically given to patients at risk of stroke, deep vein thrombo-
sis, or other types of cardiovascular disease. Though Warfarin 
I
By Steve Goldstein
GW’s Pharmacogenomics Program Explores  
Fashioning Individualized Drug Therapies
THOMAS KOHOUT
Travis O’Brien, Ph.D., director of the Pharmacogenomics program 
and associate research professor of Pharmacology and Physiology
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is prescribed millions of times each year, the drug is difficult 
to manage. It inhibits a key gene that promotes clotting, and 
it’s also deactivated by a liver enzyme. In patients who inherit 
a genetic variation in that enzyme that slows their metabo-
lisms, Warfarin gets broken down at a slower rate. This 
variation might cause the drug to stay in the body longer, and 
increase the chances of negative side effects like bleeding.
O’Brien’s research team, which includes April Barbour, 
M.D., M.P.H., associate professor of Medicine at SMHS, 
and Arthur Harralson, Pharm.D., of Shenandoah University, 
focuses on drug metabolism in African Americans. While 
there are known genes that affect the metabolism of the anti-
coagulant Warfarin in Caucasians, those that affect metabo-
lism in minorities are not well-defined, the team explained. 
“Warfarin has a narrow therapeutic window and its 
metabolism is affected by many factors, including genetic 
variation,” said Barbour. “Knowing genetic information 
helps physicians initially choose the proper dose of Warfarin 
and then manage patients over time. This has the potential to 
reduce morbidity and mortality.” 
“There’s probably no other drug in the world that has 
genetic information that’s so well-linked to the dose someone 
is receiving,” O’Brien added.
The study is still in the recruitment phase, which O’Brien 
expects to complete by year’s end. DNA will be collected 
from study subjects and then isolated and analyzed at the 
PGx program lab in Ashburn, where the samples will be 
subjected to DNA sequencing. O’Brien said such research can 
reduce health care costs “and work as a preventative measure 
to decrease the incidence of adverse drug reactions associated 
with Warfarin.”
A second area of research is in Reproductive Endocrinol-
ogy. Along with Paul Gindoff, M.D., professor of Obstetrics 
and Gynecology at SMHS, and director of GW’s Fertility 
and In Vetro Fertilization (IVF) Center, O’Brien and other 
researchers are examining genetic biomarkers in different 
populations to find a model that can predict how women will 
respond to ovarian stimulation therapy. Virtually all women 
undergoing fertility treatments receive such therapy; nearly 
10 percent of them suffer from moderate to severe Ovar-
ian Hyper Stimulation Syndrome (OHSS), a condition that 
can lead to complications such as ovarian torsion, ovarian 
rupture, and thrombophlebitis.
“This model will help patients decide whether they want 
to undergo the therapy and help physicians decide how to 
treat patients who respond poorly to it,” said O’Brien. A 
second phase of the research, he said, is a case-control study 
that examines blood samples from patients who have had 
OHSS and compares them to those who responded normally. 
If the latter is found to have a different genotype than those 
who experienced toxicity, “you could create a simple genetic 
test that will let a woman know whether she’s at risk of over-
stimulating,” O’Brien noted.
Gindoff called the research a potential “grand slam.” 
In the future, he said, predicting who is at risk to develop 
OHSS “will save a lot of people angst and medical treatment 
because we can be sure to treat them more appropriately.” He 
added that it might also indirectly increase the success rate of 
IVF because the procedure could be performed safely in more 
cases. For example, if someone is overstimulated, many times 
you can’t finish the cycle, so if you can do this more safely 
then you can finish the treatment and help more people who 
might not otherwise be helped.”
O’Brien is also excited by the prospect of targeting cancer 
with genetically tailored medications. Since cancers are typi-
cally diagnosed with a biopsy, physicians might be able to use 
those tissue samples to study the DNA of the cells. This tech-
nique could lead to selecting a drug and dosage that is most 
suitable for combating each patient’s specific form of cancer.
“All medications will be designer drugs 
someday. Pharmacogenomics will be another 
tool in the armamentarium in battling disease.” 
Travis O’Brien, Ph.D.
“One person’s liver cancer is not the same as another’s,” 
he said. “With better understanding of these variances, we 
will be able to treat cancers differently and that’s a major 
area where genetics research will have a big impact.”
O’Brien hopes that the PGx program will help to shape 
how future health care professionals think about and treat 
their patients. Joseph Bocchino, Ed.D., M.B.A., interim 
senior associate dean for Health Sciences, said that pharma-
cogenomics “specifically moves us closer to being able to treat 
a patient as an individual human being, as opposed to taking 
the results from a clinical trial with 5,000 subjects and treat-
ing an entire universe of people.”
Currently, the innovative program has 16 students. But 
Bocchino suspects it will expand. “If I was talking to a high 
school graduate, I would say that this program offers multiple 
pathways to science, the retail pharmacy business and indus-
try, and it offers a seamless route to a Pharm.D. degree,” he 
said.
For years, physicians have spoken about providing person-
alized medicine, but the reality was mainly restricted to diet, 
age, lifestyle, and health status. O’Brien believes that Phar-
macogenomics has the potential to truly realize the promise 
of the field. “It’s the ability to take genetic information and 
apply it to patient care,” he said, “which ultimately will lead 
to better health care overall.”
For more information about Pharmacogenomics research 
and GW’s Pharmacogenomics degree program, visit  
gwumc.edu/pharma.  n
12    smhs.gwumc.edu     •    S P R I N G  2 0 1 2
esum Moosavi, a third-year medi-
cal student in the George Washing-
ton University School of Medicine 
and Health Sciences (SMHS), enters the dimly 
lit hospital room. He introduces himself and 
briefly explains what he is there to do. 
The Art  
of Healing
RETIRED FACULTY MEMBERS DRAW 
ON DECADES OF EXPERIENCE TO 
TEACH THE PRINCIPLES OF PRACTICE
The patient is a heavy-set, African American male in 
his mid-40s complaining of dizziness, slight abdomi-
nal discomfort, and dark urine. 
Moosavi begins the examination by taking the 
patient’s medical history, as Robert Wilkinson, M.D., 
M.A.C.P., professor emeritus of Clinical Medicine, 
a Board Certified Internist with nearly 50 years 
of experience under his belt, sits quietly observing 
Moosavi’s interaction, his forward-leaning posture, 
eye contact, and his relaxed but methodical line of 
questions. Wilkinson takes notes as the student asks a 
series of questions aimed at developing a differential 
diagnosis. When Moosavi indicates he has completed 
the history, Wilkinson asks a few additional questions 
for clarification before the student moves on. 
Wilkinson makes notes on a 40-point checklist as 
Moosavi continues on to the physical exam, checking 
the patient’s pulse, inspecting his eyes for jaundice and 
observing their pupillary reflex, and then continues 
through the steps to an efficient physical exam. 
Gently tapping on the upper body, Moosavi listens 
carefully to the quality of the sound his fingers make. 
The difference in tone — resonant or hyper-resonant, 
flat or dull — tells a physician a great deal about 
the underlying structure. Dullness could indicate an 
underlying collection of fluid or possibly a mass.
Moosavi next guides firm but careful fingers 
over the patient’s abdomen, probing the stomach 
and tracing the outline of the liver to get a sense of 
his condition. At the end, Moosavi glances over at 
Wilkinson as if to ask, “Well, how did I do? Did I 
leave out anything?”
The two chat briefly with the patient, each thank-
ing him for his time, and then retire to debrief in an 
empty lounge, where the real learning begins. 
TEACHING THE HEALING TOUCH 
For nearly 20 years, a small band of retired SMHS 
clinicians like Wilkinson have been working to hold 
the line on hands-on care, ensuring that the doctors 
trained at GW know as much about the art of healing 
as they do about the science of medicine.
Since the early 1990s, every third-year medical 
student has taken Observed History and Physical 
Examination, a two-hour assessment of what Sir 
William Osler, the Canadian physician credited with 
first leading medical students out of the lecture hall 
and into the exam rooms, once called the “principles 
of practice.” 
The course was developed by Stanley J. Talpers, 
M.D., a long-time clinician with the George Wash-
ington Medical Faculty Associates and former SMHS 
faculty member. After teaching in the Practice of 
Medicine (POM) program for about 15 years, former 
chair of the Department of Medicine George Rios, 
M.D., urged Talpers to launch a different type of 
S
By Thomas Kohout
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program. Together they developed a course to offer 
third-year medical students an individualized critique 
of their examination and patient history skills. 
Today, Talpers and eight fellow physicians — 
mostly former internists and all with some current or 
former GW affiliation — offer up decades of bedside 
exam experience during extensive evaluation sessions.
THE DEBRIEFING
Following Moosavi’s examination, he and Wilkinson 
sit down to discuss how things went. After reviewing 
the proper use of the ophthalmoscope and the appear-
ance of the fundus, Wilkinson suggests Moosavi and a 
classmate visit the exam rooms at the Clinical Learn-
ing and Simulation Skills Center — GW’s hands-on 
clinical educational environment. Then they discuss 
the patient, whom Wilkinson had handpicked earlier 
that day, asking the patient if he would be willing 
to participate in the teaching exercise and determin-
ing whether his case would be suitable for Moosavi’s 
history and examination. 
“I thought Moosavi did quite well,” says Wilkin-
son. “When the patient didn’t want to go into details 
about his mental health history, the student didn’t 
press him or get confrontational. Ultimately he devel-
oped such a good rapport that the patient disclosed his 
mental health status anyway.”
TEACHING THE SKILLS
Each year, some 180 third-year medical students take 
this rite of passage as they move through the Depart-
ment of Medicine during their clinical rotations. They 
have already covered the skills required to take a 
patient history and give a physical exam during their 
first two years of POM. But often by the time students 
advance to their rotations something has gotten lost. 
What Talpers calls the “skill of touch” is the point 
where medicine leaves the scientific arena and moves 
into the world of art. “That art is fading,” he says. 
Those skills have diminished in value as access to 
high-tech testing equipment becomes more common-
place. When students begin their rotations, they’re 
often left dazzled by that technology, and it’s hard for 
them to recall those basic skills they’ve learned as well 
as their value. 
“The generation I came out of had little technol-
ogy,” recalls Talpers. “When I was a young doctor 
we relied heavily on physical diagnosis; that was an 
important part of a careful examination.”
Ironically, through the SMHS POM program 
and the Observed History and Physical Examination 
course, Talpers believes that today GW might actu-
ally be doing a better job of teaching these skills than 
ever before. When he was a young medical student, 
Talpers’ examination training came mostly through 
observing residents and doctors performing exams. 
“We’re teaching that now over the first two years,” 
he says. “We teach it very well and make it stick. 
That’s what this course is about — making those skills 
stick.”
An important part of this program, says Wilkin-
son, is that it’s not graded. “I explain that this is 
purely for their benefit. The students genuinely like 
the program, not just because 
they aren’t graded, but also 
because they are getting 
feedback from us. If they do 
something wrong in the physi-
cal examination we say, ‘wait, 
why don’t you try doing that 
this way.’ ” 
Following the exam, physi-
cians and students sit down to 
go over the procedure. They 
discuss how things went and 
explore ways to move beyond 
any tricky parts. Students, 
says Talpers, listen carefully 
when they’re critiqued. “We 
are giving them something invaluable, that one-on-one 
time and immediate feedback. That’s precious.”
Many students ask if they can do it over, say Talp-
ers and Wilkinson, and some have suggested each 
student get a chance to take the course at the start of 
third-year rotations and again at the end. Unfortu-
nately, there aren’t enough physicians to critique all of 
the students twice. In fact, time is a large part of why 
the course is led by retired or semi-retired physicians. 
Between the exam and the critique, physicians spend 
at least two hours with each student.
LASTING INFLUENCE
Wilkinson and Talpers agree that the goal of this 
program is not to move clinical practice back to a 
19th century mindset. Modern diagnostics are crucial 
in the treatment of serious illnesses. But, they add, 
a physician armed with good examination skills can 
pinpoint most illnesses just as effectively, possibly 
faster, and certainly more efficiently than blindly 
ordering a battery of tests.
“If we could influence our students in these two 
hours, instilling these good habits and developing the 
skills that have become part of doctoring for a very 
long time,” says Talpers, “they could do a better job 
diagnosing their patients and getting the right answer 
the first time.”  n
“We are giving them 
something invaluable, 
that one-on-one time 
and immediate feedback. 
That’s precious.”
 Stanley J. Talpers, M.D.
14    smhs.gwumc.edu     •    S P R I N G  2 0 1 2
hey were running, running. In the 
morning light, the only sounds were 
heavy breathing and the rhythmic 
flap-flap-flap of worn-down sandals 
as the tribesmen clicked through the 
scrub atop the hard baked Sudanese 
laterite. Some giggled as they followed the white 
man. “Why is this crazy khawaja using up all our 
energy? Why run unless someone is chasing you?” 
But they kept running.
T
Building 
Sudan 
on the Run
By Steve Goldstein  |  Photography Courtesy of Glenn Geelhoed, M.D. 
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Glenn Geelhoed, M.D. — surgeon, medical missionary, 
marathoner, proselytizer of peace — has indeed been called 
crazy. His latest plan — to unite the warring tribes of South 
Sudan around a marathon team to compete in the London 
Olympic Games this summer — was seen by some as wishful-
ness bordering on fantasy. 
But Geelhoed, or Doc G as he’s known in the bush, has 
defied doubts and exceeded expectations before. Indeed, he’s 
made a career of it, spending more than 40 years leading 
medical missions to the most poverty-stricken, desperately 
underserved regions of the world. In addition to ministering 
to the poorest of the poor, he’s trained generations of young 
doctors while establishing clinics in remote locations from 
Southern Sudan to the Philippines to Haiti. 
Geelhoed holds the unique distinction of being the only 
five-time GW alumnus, earning advanced degrees from 
four of the university’s 10 schools. He came to GW’s School 
of Medicine and Health Sciences in 1975, and now holds 
professorships in Surgery, International Medical Education, 
and Microbiology and Tropical Medicine. But his OR is the 
world. He’s received the American College of Surgeons’ 2009 
Volunteerism Award for International Outreach, the 2008 
Safari Club’s International Humanitarian Service Award, 
and, in 2005, was inducted into the Medical Mission Hall of 
Fame.
But the latest mission? Let’s just say it’s made Geelhoed 
acutely familiar with the old Yiddish saying, “Man makes 
plans, and God laughs.” Still, progress has been made and the 
dream lives on. There’s another saying Geelhoed prefers: “A 
journey of a thousand miles begins 
with a single step.”
The former colony of Sudan 
gained independence from the British 
in 1956, but has known little peace 
since; two civil wars have killed 
millions and displaced millions 
more. In 1983, the military regime 
attempted to impose Islamic law, 
triggering a separatist rebellion in the 
south of the country, home to a third 
of the population who hold Chris-
tian or animist beliefs. War raged 
for more than 20 years until a peace 
agreement was signed in 2005. But 
the Comprehensive Peace Accord did 
not quell the strife and the missions 
led by Geelhoed, who first came 
to South Sudan in 2005, have been 
marked by conflict, including cattle 
and bride raids, kidnappings, and 
murders.
In January 2011, South Sudan 
voted overwhelmingly for independence 
and a new state was formally declared on July 9. Intereth-
nic clashes among the Dinka people (about three million), 
the Nuer people (about two million), and the Murles (about 
400,000) persist, however, thanks to problems like the high 
rates of infertility among Murle women that motivate their 
tribe to capture Dinka brides.
Having run more than 100 marathons, with at least one 
on every continent on the globe, Geelhoed can rightly be 
called an addict. His lean, compact physique and the sharp 
planes of his face accentuate his deep-set eyes. Given the 
endorphin rush that produces a sense of well-being, Geel-
hoed, who recently turned 70 and who runs wherever he 
travels, thought that running might serve as a path toward 
peace and the restoration of health care for an impoverished 
population. Perhaps sport could be a mechanism to defuse 
ethnic rivalries, he mused.
As part of a ceasefire agreement he brokered among the 
warring tribes in early 2010, Geelhoed pledged to deliver a 
40-foot shipping container of medical equipment and a team 
of professionals to outfit clinics and train medics to treat the 
Murle and Dinka people and hopefully address the infertility 
issue. But the ceasefire didn’t hold. “Why should I talk to you 
about malaria and TB when your biggest health problem is 
hostility?” a disappointed Geelhoed told the tribes. “I’m not 
going to redevelop your health care until hostilities cease.” 
New pledges of peace were renewed. When he returned in 
January 2011 with the promised supplies, Geelhoed said they 
would only be distributed if the tribes worked together. As 
an additional carrot, he promised to rebuild the Lakurnyang 
Glenn Geelhoed, M.D., greets patients waiting outside a rural clinic.
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Missionary Hospital in Pibor in Jonglei State in the eastern 
part of the country.
Meanwhile, Geelhoed continued running. Sometimes, 
tribesmen joined him. Maybe this could be a natural way 
to commemorate the Jan. 9 vote approving a new state, he 
thought, successfully implementing a “Jonglei Freedom Run” 
in Pibor. More than 400 tribesman ran some 15 kilometers 
through the dusty scrub, vying for the honor of beating the 
khawaja. Every African who finished received a medal in the 
shape of a whistle and 10 Sudanese pounds, or about $5.
This idea has legs, Geelhoed thought. His next step was 
planning a “Jonglei Independence Run,” uniting the tribes 
in a ceremonial jaunt in January 2012 on the anniversary 
of the vote for secession. Through a connection with famed 
American marathoner Bill Rodgers, Geelhoed’s plan came 
to the attention of the organizers of the Los Angeles Mara-
thon. In return for exclusive rights to publicize the Sudanese 
connection, marathon officials agreed to pay expenses for the 
winning male and female runners from each tribe in the Inde-
pendence Run to race in the L.A. Marathon on March 18, 
Marathon t-shirts, medals, and spare running shoes, Geel-
hoed found that hostilities had resumed between the Nuer 
and the Murle tribes, leaving scores dead. Some Dinka lead-
ers, sensing better odds of going to the United States, wanted 
to go ahead with the run anyway. No way, said Geelhoed, 
in his direct, Dutch manner. “I came here for the benefit of 
all,” he said. “So the race is off, no trip to LaLa Land and 
maybe no Olympics.” The tribesmen suggested an alternate 
plan to hold the run this July on the first anniversary of the 
new state, but the rainy season would flood the racecourse. 
“There will be no race until it’s an all-tribes race,” Geelhoed 
declared.
For Geelhoed, who’s worked in Africa for four decades, 
this is merely a bump in the road. “The most likely scenario is 
I return to South Sudan in July and the tribes agree to run in 
the dry season beginning in November and then the winners 
train in Kenya,” he said. “Then all we have to do is create 
a National Olympic Committee and prepare for the 2016 
Games in Rio de Janeiro, Brazil, by training on a measured 
course.”
2012. Geelhoed leapt at the deal. Further discussion yielded a 
promise to help train the same runners to potentially compete 
as a South Sudan Olympic Marathon Team at the London 
Olympics.
So, what happens? God laughs. Returning to South Sudan 
last December to prepare for the run, bearing 750 L.A. 
Mafi mushkila (no problem), as the tribes say.
Geelhoed is convinced that sport can bridge ethnic 
divides, pointing to the unifying effect of rugby in South 
Africa and basketball in the Middle East. For him, this is one 
more mission, and a necessary step on the journey to ending 
hostilities and restoring health care. “I go out there and see 
what’s possible,” he said. “Some of the missionaries said they 
can’t believe I’ve gotten this far. You can go a long way when 
you’re not concerned with who gets the credit, and my goal is 
not to leave fingerprints. This is up to them.”  n
Left, Glenn Geelhoed, M.D., treats a Murle woman just returning 
from exile. Above, Murle people outside the Lakurnyand Clinic 
waiting to receive treatment.
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When Class  
Gets Personal 
Students examine their genomes in innovative course
By Anna Miller   |  Photography by Holger Thoss
ick Hazen’s computer screen stared back at 
him like a reflection in a funhouse mirror. 
Laid out in colorful charts, and enhanced 
through explanatory slides and expert 
quotations, it’s a visage of someone both 
familiar and unrecognizable. 
According to the graphics, Hazen was a 
30-year-old blue-eyed man of European descent who could digest 
lactose. That much he already knew. But he was also described as 
a person with a low risk for heart disease and an elevated risk for 
Alzheimer’s disease. That bit — and much more — was news. 
Hazen, a second-year medical student at the George Wash-
ington University School of Medicine and Health Sciences 
(SMHS), had sent away a swab of his saliva several weeks 
earlier to 23andMe, a company that analyzes DNA for disease 
risk, drug resistance, and ancestry. When the results popped 
into his inbox, his gene-deep journey to self-discovery began. 
But unlike most of the company’s customers, Hazen’s 
pursuit wasn’t motivated by fear, marriage, or a genetic 
counselor’s nudging. Like several dozen other GW medical 
students, Hazen was preparing for class. 
ACADEMIC INNOVATION
Tim McCaffrey, Ph.D., professor of Medicine and director 
of the Division of Genomic Medicine at SMHS, calls pushing 
the curricular envelope “academic innovation.” He knows his 
course, “GNMX201: Personalized Genomics: An Exploration 
into the Heritable Elements of Disease,” is unlike any other.
“I’ve never taught a course like this before; and as a 
matter of fact, there are only two or three medical schools 
around the country that are teaching similar courses,” he tells 
his students during the first lecture. “What’s different about 
it is that it’s interactive — you can learn things about yourself 
that you really couldn’t in other types of courses.”
That’s for sure. The course, which was first offered in 
the summer of 2011, gives each student the chance to have 
his or her genetic makeup, or genome, scanned by 23andMe 
for more than one million variations in DNA called Single 
Nucleotide Polymorphisms (SNPs). The company compares 
the individual’s outcomes with a database of SNPs to predict 
the relative likelihood of developing more than 100 diseases. 
Their results can be viewed by logging into a personalized 
page on the 23andMe website. 
McCaffrey’s students can opt to work with an anony-
mous set of DNA. However, most — if not all — use their 
own. The program not only reveals personal risk for disease, 
it also teaches the students about each condition through 
slides, video explanations, and a physician’s perspective. 
The website is satisfying even “for those of us who are really 
super wonky,” says McCaffrey, because it describes precisely 
which gene is affected by the variation, where it is located 
in the genome, and how it’s connected with disease. For the 
skeptical type, 23andMe links to the studies that support 
its conclusions and updates users’ results as new research is 
released. “It’s a hypochondriac’s dream,” McCaffrey adds. 
It’s also a professor’s dream: the ability to personalize 
lessons that would otherwise be hypothetical. Using the 
students’ experiences with the program as the backdrop 
makes class discussions on DNA sequencing, guest lectures 
N
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about the statistical methods behind risk assessment, and 
readings regarding the ethical, legal, and social issues 
surrounding genetic analysis all come to life. McCaffrey 
records each lecture so that his students — some of whom 
travel internationally pursuing research projects through the 
Gill Fellowship Program, which awards medical students 
a summer stipend for conducting research with faculty 
members — can watch them from around the world or refer 
to them from their homes. 
As the syllabus promises, “By exploring their own genome 
and heritable disease risk … the student will become familiar 
with the terminology, the methods, the proper interpretation, 
as well as the strengths and weaknesses of this approach. 
Because patients are now obtaining this information on their 
own … this is an eminently practical course that will foster 
an informed and responsive physician.”
WE ARE ALL SUSPICIOUS
McCaffrey presumes that most students are drawn to his 
class, an elective, out of curiosity. “Whether we like it or 
not, we all are suspicious of what we are at risk for,” he says. 
“Tapping into that curiosity helps us engage students in learn-
ing about the genetic contribution to disease.” 
For Hazen, whose family has a history of heart attacks 
and strokes, those suspicions were related to his heart. But 
23andMe had different hunches, illustrating a key concept 
of the course: there’s a difference between family history 
and heredity.
“Up until now, family history has pretty much been 
taken as indicative of there being some heritable predispo-
sition involved in a particular disease or condition,” says 
McCaffrey. “We know now that 
a familial risk and genetic inheri-
tance are not identical concepts.”
GNMX201 also stresses the 
important difference between 
disease risk and diagnosis. McCaf-
frey, for example, is more than 
two times as likely as the average 
person to develop Crohn’s disease, 
according to his 23andMe results. 
But with a risk of 1.2 percent, his 
chances are still small. 
Whether or not an elevated risk 
progresses into an actual diagnosis 
depends, to varying degrees, on 
both nature and nurture. Some 
diseases, namely Alzheimer’s and 
Parkinson’s, however, are believed 
to be almost exclusively nature — 
so much so that a consumer’s risk 
for them is guarded by an extra 
“lock” on 23andMe. 
“[Unlocking the information] is a decision you should 
really think about because as far as we know, there’s almost 
nothing you can do about [those diseases],” says McCaffrey. 
“I tell the students ‘don’t do it, don’t look. You have nothing 
to gain by it. If it’s going to affect you at 50 or 60 years old, 
why would you want to worry about it now when it might 
well be cured by then?” 
ACTIONABLE INFORMATION
Fortunately, dead-end information is rare in personal-
ized genomics. Most of what’s gained is “actionable,” 
says McCaffrey, and can be used to influence behavior 
change, initiate doctor-patient discussions, or inform 
medication dosages. 
Personalized genomics is, by its very definition, personal. 
But for students who take GNMX201, its real value is not 
what they learn about themselves, but what they learn about 
patient care. 
“People are doing this — and they’re doing it without 
their physicians,” says McCaffrey. “Then, they go to their 
physician, and the physician doesn’t have a clue what they’re 
talking about because they were trained 30 years ago. They 
just don’t know how to deal with it.”
But with the help of courses like McCaffrey’s, the next 
generation of physicians will know how to deal with it. After 
all, they will have gone through it themselves. 
“This course is not required, and it won’t be on the 
boards,” says Hazen. “But it’s a perfect example of how GW 
does a good job preparing us for life after medical school: It’s 
offered for the purpose of making us better physicians.” n
Tim McCaffrey, Ph.D., discusses the implications of personalized genomics.
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A Legacy of 
Discovery
By Steve Goldstein  |  Photography by Michael Leong
20    smhs.gwumc.edu     •    S P R I N G  2 0 1 2  M E D I C I N E  +  H E A LT H        21
ome are born scientists, some have science thrust upon them and, in the 
case of Michael I. Bukrinsky, M.D., Ph.D., some have a family history 
that conveys a certain inevitability to their life’s work. Fortunately for the 
George Washington University School of Medicine and Health Sciences 
(SMHS), where Bukrinsky serves as professor and interim chair of the 
Department of Microbiology, Immunology, and Tropical Medicine, his family was also 
instrumental in ensuring that his groundbreaking work in HIV biology and drug design was 
done in the United States and not in his native Russia.
With a research focus on HIV biology and inflammatory 
diseases, Bukrinsky and his team have been studying cardio-
vascular disease in HIV-infected patients. In addition to his 
leadership role in the department, Bukrinsky is one of the 
senior researchers leading GW’s Washington, D.C. Develop-
mental Center for AIDS Research (D.C. D-CFAR), which is 
charged with providing scientific leadership and institutional 
infrastructure to promote HIV/AIDS research and to develop 
the next generation of investigators. 
Yet all of this might never have been.
Science is literally in Bukrinsky’s DNA. His father, Ilya 
Shapiro, was a prominent biologist and his mother a virolo-
gist. When they weren’t working at their labs, his parents 
poured over difficult-to-obtain scientific journals, which were 
in short supply in the Cold War-era Communist Soviet Union. 
“I saw them reading all the time and they seemed happy 
and excited,” recalled Bukrinsky, “so by age 10 or 11, I had 
decided that I was going to be a scientist, too.” His parents 
sent him to Moscow School No. 2, the top mathematics 
school in the city, whose director would later be persecuted 
by the Soviet authorities for allowing too much free speech. 
Later, Bukrinsky would attend Moscow Medical School 
and earn his Ph.D. at the prestigious Institute of Molecular 
Biology.
Meanwhile, in 1978, Shapiro defected to the West to 
escape the Soviet Union’s restrictive working conditions for 
scientists. With his father branded a traitor, young Michael 
took his mother’s maiden name — Bukrinsky. (Augment-
ing his scientific pedigree, Bukrinsky’s mother later married 
Viktor Zhdanov, a famous Russian virologist and Deputy 
Minister of Health in the USSR, who led the effort to eradi-
cate the smallpox virus.) By the mid-1980s, Bukrinsky began 
to relate to his father’s frustration. “I rose to ‘interim junior 
researcher,’ ” he said with a laugh. “It was a joke; I had no 
real position.” The final straw came when Soviet authorities 
rejected an invitation for Bukrinsky to visit Cuba to address 
the nation’s growing HIV problem.
In 1989, the last year Jewish people were allowed to 
emigrate from the Soviet Union, Bukrinsky received an offi-
cial invitation to leave, thanks to his father’s friend in Israel. 
Ultimately, Bukrinsky went to the United States; his mother 
would follow three years later, after the dissolution of the 
USSR. “I left because I wasn’t allowed to move to any posi-
tion where I could do something in research,” he explained. 
Shapiro was also instrumental in matching his son with 
leading HIV researcher Mario Stevenson, Ph.D., at the Univer-
sity of Nebraska in Omaha. It was a good fit: Bukrinsky 
stayed for three years and the lab published numerous papers 
in top journals. “This was the time my future interests were 
formed,” said Bukrinsky. Then fate took another turn when he 
met Anthony Cerami, Ph.D., who was head of a research insti-
tute at North Shore University Hospital on Long Island, N.Y.
“We had decided to expand the scope of our research to 
include HIV and, after calling people in the field, we identi-
fied a young investigator named Michael Bukrinsky,” said 
Cerami, a distinguished researcher who pioneered the hemo-
globin A1c test used by diabetics worldwide and founded the 
Warren Institute, a not-for-profit that conducts biomedical 
research. “I worked with Michael on several aspects of HIV 
and enjoyed every moment. He is without a doubt one of the 
leaders in the field today,” said Cerami.
The two became close friends and when Bukrinsky 
expressed a desire to find a new position, Cerami endorsed 
GW, which was actively expanding its Department of 
Microbiology, Immunology, and Tropical Medicine. In 2001, 
Bukrinsky arrived on campus and, in a short time, according 
to his peers, managed to rise to the top of a highly competi-
tive HIV/AIDS field. He’s also become an admired mentor, 
training doctoral students who have gone on to some of the 
best laboratories in the world. One of them, Sergey Iordans-
kiy, Ph.D., was a postdoc from 2001 through 2007 and now 
continues to collaborate with Bukrinsky as a member of the 
research faculty at GW. “Michael is a fantastic mentor and 
scientific adviser who allows us to work almost independently. 
S
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He always considers the opinions of young scientists and 
guides them in the right direction when problems arise,” said 
Iordanskiy. 
Bukrinsky’s lab has focused on, among other projects, 
analyzing cholesterol metabolism in HIV-infected cells to 
understand why people with HIV are at increased risk of arte-
riosclerosis. As anti-retroviral drug regimens have allowed 
HIV patients to live longer, a clinical problem has arisen 
because they are developing arteriosclerosis at an earlier age 
than the general population. At first, Bukrinsky said, experts 
thought that the increased risk was related to the drugs, but 
that theory was proved false. “In fact, tests showed that when 
taken off drugs, the risk actually went up — not down,” said 
Bukrinsky. “That’s when we came in with our project.”
Bukrinsky’s finding that the replication of HIV itself is in-part 
dependent upon cholesterol metabolism. The viral effect on 
cholesterol metabolism and trafficking has been observed in 
other viruses, suggesting that it can be used as a target for 
therapeutic approaches against HIV as well as other viruses. 
“This creates the opportunity to perhaps control the replica-
tion of HIV,” said Remaley. As a result of these observations, 
Bukrinsky is cited as an author on more than 10 U.S. patents.
With 2011 marking the 30th anniversary of the battle 
against HIV/AIDS, Bukrinsky’s work comes amid other 
breakthroughs such as the discovery that an HIV-infected 
individual can reduce the risk of sexual transmission by 
beginning anti-retroviral drug treatment sooner. Other 
successful interventions have helped prevent HIV-infected 
mothers from transmitting the virus to their children during 
birth. All are steps toward what the Obama administration 
calls an “AIDS-free generation.”
“A vaccine will be the ultimate solution for the epidemic, 
but I don’t think this would solve all the problems,” said 
Bukrinsky. “To me, the real solution would be to cure the 
disease, to make people who have it free of the virus.” To this 
end, Bukrinsky’s research has focused on the use of thera-
peutic, not preventative, vaccinations. His lab is working to 
better understand latently infected cells, which remain in the 
body throughout a patient’s life and may become active when 
drug therapy is stopped. 
In addition to his administrative responsibilities as acting 
chair, there is Bukrinsky’s work with the D.C. D-CFAR, 
where he directs two of the five “cores” that provide support 
for HIV-related research in Washington. He is in charge of 
the developmental and basic science cores; the other three 
include administrative, clinical and behavioral science, and 
prevention and biostatistics. He has noted a shortage of HIV/
AIDS researchers doing basic science work and said, “this 
is an area we need to develop in order to support the other 
research studies [and] the only way to accomplish that is to 
attract new people, especially young investigators.”
For Bukrinsky, that “next generation” begins at home. His 
youngest daughter is in high school, his oldest daughter is a 
lawyer in Virginia, and his son just started medical school in 
Grenada. Not surprisingly, his wife, Tatiana Pushkarsky, is a 
research scientist in his department at SMHS.
Thinking back to those nights watching his parents read 
scientific journals at home, Bukrinsky sees the same sense 
of excitement and discovery in the young researchers he’s 
mentored. He doesn’t regret his decision to “escape,” as he 
has put it. “If I had stayed in Russia, I’d still be a scientist, but 
I wouldn’t be able to do what I’ve achieved here,” he said. “I 
know I did the right thing.”
For more information about Michael Bukrinsky, M.D., 
Ph.D., visit www.gwumc.edu/bukrinsky.  n
Bukrinsky’s team discovered that the HIV virus has a 
specific effect on cholesterol metabolism by inhibiting a criti-
cal cholesterol transporting mechanism. Specifically, the HIV 
virus suppresses cholesterol efflux, which is critical for matu-
ration of the high-density lipoprotein (HDL) particles, the key 
atheroprotective factor in blood. The HDL particles perform 
two functions: anti-inflammation and prevention of plaque 
formation in the arteries. But HIV patients have low levels of 
HDL, explains Bukrinsky. 
Once the role of HDL in arteriosclerosis was discov-
ered, pharmaceutical companies went to work on drugs that 
stimulate the transportation of cholesterol. Bukrinsky’s team 
capitalized on these developments, finding that the same 
drugs also inhibit viral replication. “This suggests that these 
drugs will be of dual benefit to the patients — they will not 
only fight arteriosclerosis but they’ll also inhibit replication of 
the HIV virus. This is really very exciting,” Bukrinsky said.
Alan Remaley, M.D., Ph.D., a well-known HIV expert 
at the National Institutes of Health, said Bukrinsky’s work 
on the role of cholesterol and lipid metabolism in AIDS 
“holds great promise” regarding the effect of some HIV 
drugs on lipid and lipoprotein metabolism. He also praised 
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Matter Over Mind 
RESEARCHERS IDENTIFY GENE INVOLVED  
IN WHITE MATTER DEVELOPMENT
t first, Li-Jin Chew, Ph.D., research assistant 
professor of Pediatrics at the George Washing-
ton University School of Medicine and Health 
Sciences (SMHS), and Vittorio Gallo, Ph.D., 
professor of Pediatrics and of Pharmacology 
and Physiology at SMHS, were in the dark.   
Their eight-year venture to better under-
stand how the brain makes and repairs myelin — a coating 
that insulates the axons of neurons and that, as a whole, is 
referred to as white matter — began slowly with little funding 
and few clues.  
“At the beginning, there were many reasons we were 
crawling,” admits Chew, who is an investigator at the Center 
for Neuroscience Research at the Children’s Research Institute 
at Children’s National Medical Center (Children’s National), 
where Gallo is director and Wolf-Pack Chair in Neuroscience.
A break in the clouds came during an early screen, when 
the lab found that a gene called Sox17 was being regulated 
during myelination, or the formation of white matter.  
Although pinpointing this gene was no minor accomplishment 
(the finding was published in The Journal of Neuroscience in 
2006), it left questions unanswered. What function did Sox17 
have, and how does it work?  
The researchers knew the answer wouldn’t come easy. The 
gene, which resides in many types of cells and is expressed 
only weakly and temporarily in developing white matter, is 
inherently difficult to study. 
But recently, the Chew-Gallo team reached a major turn-
ing point in their research. In a study published online in 
the September 2011 edition of The Journal of Neuroscience, 
they identified Sox17 as a gene that helps direct immature 
brain cells (called oligodendrocyte progenitor cells) to mature 
and generate myelin through its regulation of the Wnt/beta-
catenin signaling pathway, a major pathway implicated in 
white matter development and in some forms of brain cancer. 
A glitch in these signals can result in mental retardation, 
developmental disabilities, and diseases of adult white matter 
such as multiple sclerosis.
“We were very excited because we were beginning to get 
a coherent picture of the interplay between these molecular 
mechanisms and the pathways that regulate oligodendrocyte 
development,” says Gallo. “The more we understand molecu-
lar mechanisms, the more we open our possibilities to target 
them with specific drugs.”
While the development of oligodendrocytes is studied 
widely, Chew and Gallo’s team is the only group to study 
Sox17’s role in this process. They are working toward renew-
ing the NIH grant they were awarded five years ago, and are 
collaborating with researchers in France on a project funded 
by the National Multiple Sclerosis Society. 
“We are very interested in expanding this study to under-
stand the relevance of this gene in human cells and pathol-
ogy,” says Gallo. 
The success of the Chew-Gallo lab — which has trained 
top researchers in white matter development, including Jiho 
Sohn, Ph.D., who led the 2006 study as a GW graduate 
student and is now studying myelination as a postdoctoral 
fellow at the University of California, Davis, and Shibeshih 
Belachew, M.D., Ph.D., an initiator of the first screen who 
has since established the largest center for multiple sclero-
sis research and clinical care in Belgium — is attributable 
to teamwork and the robust environment for neuroscience 
research at Children’s National and at GW, home of the GW 
Institute for Neuroscience, they say. 
“I think this study really exemplifies what we are all doing 
at GW and Children’s National,” says Gallo. “We are identi-
fying mechanisms that might be used to manage abnormali-
ties in disease.”  
For more information about the Center for Neuroscience 
Research at Children’s National, visit www.childrensna-
tional.org/research/OurResearch/centers/neurosci-
ence/default.aspx.  n
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onna Christensen, M.D. ’70, never intended 
to go into medicine. When her father, a former 
United States Attorney and Judge in the U.S. 
Virgin Islands, suggested she consider a career 
as a physician, the strong-willed island-girl 
from St. Croix wouldn’t hear of it. Although 
she says she was always interested in science 
and biology, becoming a doctor was a decision that came 
later. Christensen never intended to go into politics either, but 
somehow a series of influential moments ultimately led her to 
GW’s School of Medicine and Health Sciences (SMHS). From 
there Christensen developed a successful career in family 
practice, became the first female physician to serve in the 
House of Representatives, and most recently, Christensen will 
serve as the keynote speaker at her alma mater’s graduation 
ceremony on May 20. 
ALUMNA PROFILE
Medicine came to Christensen in the midst of her 
sophomore year at Indiana’s St. Mary’s College, where she 
was studying biology. “I picked up some pamphlets about 
the need for African American doctors for a friend of mine,” 
admits Christensen. Fortunately, she decided to read them 
first, before sending them along. “After that I knew I wanted 
to go into medicine. I was probably heading that way all 
along, but I didn’t want to my father to think that he had 
been right.”
Her introduction to SMHS came a short time later, when 
her father was a patient at GW Hospital. While her father was 
there for eye surgery, Christensen was busy grilling his doctor 
about GW’s medical program. Based on the doctor’s candor 
and his recommendation, Christensen chose GW.
“I was scared to death when I came,” she says, adding 
“but GW had a very different atmosphere. All of the faculty 
Where Opportunities Lead
Rep. Donna Christensen, M.D. ’70, Follows the Path from St. Croix to Capitol Hill 
By Thomas Kohout
Rep. Donna Christensen, M.D. ’70
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told us, ‘You’ve made it. We expect you all to graduate, and 
our doors are always open if you need any help.’ That made 
all the difference.”
Washington, D.C., in the late 1960s was a good fit as well. 
Vibrant and enticing, Vietnam war protestors and civil rights 
marchers filled the city’s streets. Christensen and a cadre of 
classmates spent their free time studying or just unwinding 
at the P Street Beach near her Dupont Circle apartment, and 
often found themselves at the center of everything.
She was a second-year student in 1968 when Martin 
Luther King was assassinated. When the news broke, some of 
her classmates thought that Christensen should leave the city 
for her own safety. “We were a close-knit group and looked 
out for each other. They were worried about me; afraid the 
city might not be safe. 
“I said, ‘No, it’s safe,’ ’’ recalls Christensen, but she ended 
up spending the weekend alone, watching from the rooftop of 
her apartment building as National Guard troops patrolled 
the streets below and the city burned.
Christensen instead volunteered in the medical van during the 
two-week campaign. She cared for the demonstrators who 
came from all over the country, most of whom came from the 
rural South, and the experience had a lasting effect. 
“I was just finishing my second year at the time,” she 
explains. “It was raining and muddy, and very difficult for 
everyone. That experience is why I’m serving in Congress 
today. It wasn’t a direct connection, but as I look back on it, I 
think it set a direction for me.”
Over more than two decades as a family practitioner, 
Christensen served in clinics and hospitals throughout St. 
Croix, eventually became acting Commissioner of Health. 
From there her political life began. In 1996, after a conten-
tious campaign against Victor Frazer, Christensen won the 
first of seven consecutive elections to represent the U.S. Virgin 
Islands, a tiny Caribbean territory just east of Puerto Rico.
Despite her status as a non-voting member (territories are 
not permitted to vote on legislation), Christensen has found 
an avenue to represent her constituents: committee work. 
Currently she serves on the influential House Commit-
tee on Energy and Commerce, which has a hand in 
just about every issue that comes before Congress. 
When she first arrived on Capitol Hill, Christensen 
found willing mentors in Maxine Waters (D-Calif.) 
and Louis Stokes (D–Ohio), who started the Congres-
sional Black Caucus’ Health Brain Trust. 
When Stokes retired, Christensen was tapped to 
fill his place as chair of the Health Brain Trust. That 
opportunity provided Christensen with a platform to 
address health issues. It also led to a seat on the health 
subcommittee and a major role in health care reform 
legislation. Christensen and her staff began crafting 
benchmarks for the legislation, forming a coalition 
with the Hispanic and Asian caucuses to identify some 
“non-negotiable” items — such as data collection 
by race, ethnicity, and other socio-economic factors 
— that the groups felt were an essential part of any 
health care reform law. 
The result is a law Christensen believes is a land-
mark piece of legislation as significant as anything 
Congress has crafted in generations. 
In May, when Christensen addresses the graduating 
medical students, she will encourage them to celebrate their 
accomplishments and embrace unique opportunities that 
arise. As in Christensen’s career, it is not always predictable 
where these opportunities will lead, however, they can serve 
as a guide to great things.
For more information about how to get involved at GW 
visit www.gwumc.edu/getinvolved.  n
Just a month later, events in Washington would prove 
even more pivotal for Christensen. The District was the site 
of the Poor People’s Campaign. Billed as the second phase of 
King’s civil rights campaign, the event aimed to promote an 
anti-poverty agenda that included housing, health care, and 
economic assistance for America’s poor. In May 1968, thou-
sands of demonstrators descended upon the National Mall 
and hastily built a shantytown known as “Resurrection City.”
Rather than spending those days studying for her boards, 
Donna Christensen, M.D. ’70, (at left facing the camera) relaxing with 
classmates on the P Street Beach.
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Action Unlimited
RISING FOURTH-YEAR DANIEL O’NEILL BALANCES HIV 
ACTIVISM WITH LIFE AS AN M.D./M.P.H. DEGREE STUDENT
urrying into a Dupont Circle sandwich shop 
during a break in his preceptorship at a private 
practice specializing in HIV patients, Daniel 
O’Neill wolfed down his lunch and prepared 
for his busy afternoon. A type 1 diabetic since 
he was 13, the rising fourth-year student at 
the George Washington University School of Medicine and 
Health Sciences (SMHS) is aware that controlling his blood 
sugar is the only way he can manage his extremely active 
schedule as an activist, HIV awareness campaigner, and 
M.D./M.P.H. degree student.
In 2011, O’Neill, 30, was one of 34 scholars, chosen 
from 2,000 applicants, to receive a scholarship from Point 
Foundation, the nation’s largest scholarship-granting 
organization for lesbian, gay, bisexual, and transgender 
(LGBT) students of merit. Jeffrey S. Akman, M.D. ’81, 
G.M.E. ’85, interim vice president for Health Affairs and 
dean of SMHS, said O’Neill “is a great example of the kind 
of citizen-leader that the school is proud to support.”
O’Neill graduated with degrees in Biology and Dance 
from Indiana University, where he also received a fellowship 
to obtain his M.B.A. in Biotechnology Enterprise. Upon 
moving to the area, he co-founded the HIV Prevention 
H
Daniel O’Neill plans to pursue a residency in 
Washington, D.C. or possibly San Francisco, 
where he will continue to work on HIV/AIDS 
and other public health issues for the benefit 
of the underserved and the LGBT community. 
Working Group of the Washington, D.C. LGBT Center, as 
well as an organization that distributes safer-sex kits. He is a 
recipient of the Unsung Hero Award from Caron Treatment 
Centers, a nationally recognized non-profit provider of 
alcohol and drug addiction treatment, and won a National 
Health Service Corps scholarship. And in between his studies 
and his work with the HIV Prevention Group, he sings with 
the Gay Men’s Chorus of Washington, D.C.
O’Neill, whose father is a cardiothoracic surgeon, became 
interested in medicine at a young age. Later on, he came to 
understand the parallels between HIV and diabetes, both 
chronic diseases that last a lifetime.
O’Neill said that his diabetes forces him to be as 
regimented as possible with his busy daily schedule. It’s also 
inspired him to pursue a career in outpatient care, as opposed 
to a field like surgery, that’s subject to more unpredictable 
demands.
He plans to pursue a residency in Washington, D.C. or 
possibly San Francisco, where he will continue working 
on HIV/AIDS and other public health issues. Above all, he 
said, “I want to work with the underserved and the LGBT 
community.” n
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Lead Runner
RESIDENT MARY TANSKI KEEPS ONE  
STEP AHEAD OF THE NEXT EMERGENCY
mergency medicine is unpredictable. Emergency 
medicine at the George Washington University 
Hospital is really unpredictable, as third-year resi-
dent Mary Tanski, M.D., discovered.
“You never know who or what’s going to come 
through the door,” she said during a break from 
the rigorous pace. “You get to treat patients from 
all walks of life, with every disease process. In one bed there 
might be a VIP and in the next there might be a person from a 
medically underserved community. It keeps it interesting.”
The Detroit-area native and graduate of Michigan State 
University and Wayne State University School of Medicine 
always seems to be on her toes, whether she’s treating patients 
or representing her fellow residents on various committees. 
Tanski is one of two co-chairs of the Residents Commit-
tee, which is responsible for bringing residents’ concerns to 
the attention of the administration. And, as the residents’ 
representative on the Medical Executive Committee, she is 
also charged with presenting these concerns to the commit-
tee of attending physicians and board members. “It’s very 
E
As of July, Mary Tanski, M.D., will be one 
of three chief residents for the Emergency 
Department, in charge of everything from 
residents’ schedules to new intern orientation. 
interesting to hear about long-term plans at the hospital. My 
participation in the meetings gives the residents a voice in 
discussions about the future of GW Medicine,” she said.
As of July 1, Tanski will be one of three chief residents for 
the Emergency Department. The chief residents are in charge 
of everything from residents’ schedules to new intern orienta-
tion and social activities. 
According to Robert Shesser, M.D., chair of the Depart-
ment of Emergency Medicine in GW’s School of Medicine and 
Health Sciences, Tanski “was the unanimous choice of the 
faculty and her peers to be one of our chief residents. She has 
become an excellent clinician who communicates well with 
patients, nurses, and physicians and has demonstrated excel-
lent administrative and problem solving skills.”
The stress of emergency medicine has never been too much 
for Tanski, whose devotion to running helps keep her both 
sane and slim. “If you’re working with a good team, it makes 
it all manageable,” she added. 
Tanski has envisioned her life as a physician since she was 
in seventh grade, when she wrote a report on Ben Carson, 
M.D., a fellow Michigan native and an internationally 
renowned neurosurgeon. “His story was so inspiring. From 
that moment, I knew I wanted to do this,” she said. 
Her dedication hasn’t strayed since. Following her resi-
dency, Tanski is aiming for an administrative fellowship. 
“I’m really concerned about quality improvement and patient 
satisfaction,” she said. “It’s definitely my career path.”
Shesser hopes that path will also include positions of 
leadership.
“I sincerely hope that she chooses academic medicine as 
a career because she has the potential to make a tremendous 
impact on future generations of physicians,” he said. n
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PHILANTHROPY
Well Integrated in Health
JOHN AND KATHERINE PAN TURN A LONG-STANDING ASSOCIATION WITH GW’S 
SCHOOL OF MEDICINE AND HEALTH SCIENCES INTO A MAJOR COMMITMENT
However, in 1998, John took a leap 
of faith and refocused his career on 
Integrative Medicine, at a time when 
the discipline was hardly an accepted 
practice. With support from SMHS, 
he launched The Center for Integrative 
Medicine.
The principles of Integrative Health 
are based on establishing a healing 
environment where complementary 
and alternative therapies partner 
with conventional medical practice to 
promote healing and wellness. The idea 
is to develop a care plan tailored to fit 
each patient’s needs, honor the personal 
healing process, and treat the patient as 
a whole, addressing the root cause of 
disease as well as the symptoms. John’s 
Center has been a part of the research 
and education at SMHS since it was 
established, and Integrative Medicine 
has been a popular discipline available 
through SMHS’s track program offered 
by the Office of Student Opportunities. 
The track program enables students to 
move beyond the core curriculum to 
emphasize one of nine available elective 
paths. 
“My goal is not to have a specific 
department or some stand-alone entity 
called Integrative Health,” explains 
John. “I think the principle of the 
practice is that it’s integrated through 
the health education system.” The idea, 
adds John, would be to incorporate 
aspects of Integrative Health across 
multiple disciplines in Medicine and 
Health Sciences.
In April, he accepted an invitation 
to become a member of the Dean’s 
Council for SMHS, a key advisory and 
leadership body for the school. John 
is working with SMHS to create an 
academic home for Integrative Health, 
as it is currently based in the Center 
for Integrative Medicine, which is an 
independent private practice located in 
Foggy Bottom.
John and Katherine Pan
ith a connection to the GW medical community spanning more 
than 30 years, it’s safe to say that John and Katherine Pan, and 
their family, are deeply entwined in the George Washington 
University community. John graduated from the GW School of 
Medicine and Health Sciences (SMHS) in 1970, and completed 
his residency in Obstetrics and Gynecology in 1974; and Kath-
erine earned her master’s degree in Economics at GW in 1976. 
Their son Eric and his wife, Krista, are also part of GW; as Eric earned his M.D. at 
SMHS in 2009, and now he’s in his second year of residency at GW; and Krista is 
currently pursuing a master’s degree in Education.
For many years following the completion of his residency at GW, John ran a 
private practice as an OB/GYN. In 1995, he brought his practice to the GW Medi-
cal Faculty Associates and taught GW medical students the important skills needed 
to be a successful gynecologist. continued on page 36
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Wartofsky Receives GW  
Alumni Achievement Award
Leonard Wartofsky, M.D., M.P.H., a four-time GW alumnus, was 
among those to receive the 75th Annual GW Alumni Achievement 
Award during Alumni Weekend 2011. The awards are the highest form 
of recognition that the University and the GW Alumni Association 
bestow upon alumni each year.
A thyroid cancer expert, Wartofsky earned his B.S. from GW in 
1959, a well as an M.S. in 1961, an M.D. in 1964, and an M.P.H. in 
1995. He currently serves as the chair of the department of Medicine 
at the Washington Hospital Center. In addition, he holds faculty 
appointments at GW, Georgetown University, Howard University, 
the University of Maryland, and the Uniformed Health Services in 
Bethesda, Md.
“Throughout his long and distinguished career in medicine, 
Leonard has embodied the great traditions and most important 
values of our school, as well as those of the medical profession,” 
said Jeffrey S. Akman, M.D., ’81, G.M.E. ’85, interim vice president 
for Health Affairs and dean of the GW School of Medicine and Health 
Sciences. “He is a brilliant physician and scientist who has been at 
the top of his field for many years, and I can think of no one who is 
more deserving of this award.”  n
Global Service
Christopher L. Barley, M.D. ’93, was one of five George Washington 
University alumni to receive the 51st Annual Alumni Outstanding 
Service Award. The Alumni Outstanding Service Award is given to 
alumni who advance the mission of the university through dedicated 
volunteerism in support of its programs, thereby ensuring the 
university’s impact on our community and future generations of 
students. 
Barley is a member of the School of Medicine and Health Sci-
ences (SMHS) Dean’s Council and was instrumental in establishing 
the SMHS Young Alumni group in New York City — the school’s first 
alumni group of its kind.
He is a vice president of Citta, a not-for-profit organization that 
builds and maintains hospitals and schools in rural areas of India, 
Nepal, and Mexico. In this role, Barley oversees the delivery of health 
care and education to underserved communities. He also serves as a 
Diplomat of the American Board of Internal Medicine. 
Barley’s Internal Medicine practice in Manhattan, N.Y., focuses 
on travel medicine as well as the prevention and early detection of 
diseases such as cancer and heart disease.  n
GW Alumnus Named 
President-Elect of Medical 
Society of Virginia
Russell C. Libby, M.D. 
’79, B.S. ’74, F.A.A.P, 
began his term as 
president-elect of the 
Medical Society of 
Virginia, a professional 
association serving 
Virginia physicians since 
1824, in fall 2011.
Libby is founder, 
president, and medical 
director of Virginia Pediatric Group, Ltd. in 
Fairfax, Va., serves as chief of the general 
medicine section of Inova Fairfax Hospital 
for Children, and sits on the board of 
directors of the American Academy of 
Home Care Physicians. 
In addition to his clinical work, Libby 
helped establish the GW School of 
Medicine and Health Sciences’ Adopt-A-
Doc program, through which alumni can 
support an incoming medical student’s 
education with a minimum gift of $20,000 
over four years. For information about 
giving opportunities such as Adopt-A-
Doc, visit smhs.gwu.edu/connect/
smhsgivingopportunities.cfm.
“For more than 30 years, Russell Libby 
has been a committed physician and a 
dedicated member of the SMHS alumni 
community,” said Jeffrey S. Akman, 
M.D. ’81, G.M.E. ’85, interim vice president 
for Health Affairs and dean of the GW 
School of Medicine and Health Sciences.
He also has been recognized as the best 
pediatrician in the Washington metropolitan 
area by Families Magazine, listed as 
one of best physicians by Washington 
Consumer Checkbook, as a Top Doctor by 
Washingtonian Magazine, and as one of 
the 100 top physicians in the Washington 
metropolitan area by Northern Virginia 
Magazine.  n
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1950s
MEMBERS OF THE CLASS OF 1954 gath-
ered in downtown Washington, D.C. 
during Alumni Weekend on Sept. 17, 
2011, for an afternoon of reminiscing 
and reconnecting. In attendance were: 
Solomon Barr, M.D.; Milton Boyd, 
M.D.; Robert Bullock, M.D.; Martin 
Davis, M.D.; Albert Modlin, M.D.; and, 
Ruth Oartel, M.D.
1960s
STEPHEN H. MANDY, M.D. ’66, was 
appointed to the Board of Directors for 
the American Academy of Dermatology, 
and will serve through 2016. He also 
serves on the board of the American 
Society of Dermatologic Surgery. 
DONALD BERNSTEIN, M.D. ’68, recently 
retired after 39 years practicing anesthe-
siology to become a senior scientist with 
Sotera Wireless, where he is working 
to develop rapid response monitoring 
devices.
1970s
PETER C. FREIS JR., M.D. ’70, was selected 
as one of New Jersey’s best physicians 
by N.J. Top Docs in January 2012. 
MARC A. MUGMON, M.D. ’73, was recently 
elected Governor of the Maryland 
chapter of the American College of 
Cardiology. 
MICHAEL E. CAIN, M.D. ’75, was recently 
appointed to serve as the vice president 
for health sciences at the School of 
Medicine and Biomedical Sciences at 
the University of Buffalo. Cain has 
served as the school’s dean since 2006.
BRUCE E. RUBIN, M.D., G.M.E. ’77, serves on 
the executive board for the Maryland 
Radiologic Society and the Washington, 
D.C. Metropolitan Radiologic Society.
1980s
ROBIN J. HAMILL-RUTH, M.D. ’80, associ-
ate professor of Anesthesiology and 
Critical Care Medicine, and director, 
Clinical Pain Research, at the University 
of Virginia Medical Center was named 
president-elect of the American Board 
of Pain Medicine in February 2012. 
Previously she served on the Board as 
Credentials Director. She will serve 
as president-elect from 2012–14, and 
then she will become president for the 
2014–16 term.
RICHARD KOVAR, M.D. ’80, was named 
2012 Family Physician of the Year by 
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the American Academy of Family Physi-
cians. The award honors outstanding 
family physicians who provide patients 
with compassionate and comprehensive 
care. 
MICHAEL J. VENDRELL, M.D., G.M.E. ’80, 
recently founded Ikonopedia, LLC. The 
company offers image-driven reporting 
and an encyclopedia of breast imaging. 
JERRY OSHEROFF, M.D. ’86, Clinical 
Decision Support academic at the 
University of Pennsylvania Health 
System, recently launched an 
independent consulting firm, TMIT 
Consulting, LLC. The firm specializes 
in synthesizing, disseminating, and 
implementing best-practices for 
improving health care outcomes. In 
2009, Osheroff was the lead author 
of the award-winning resource guide, 
Improving Outcomes with Clinical 
Decision Support: An Implementer’s 
Guide. 
JEFFREY FISCHGRUND, M.D. ’87, was 
selected to serve on the Board of 
Directors for TranS1 Inc., a medical 
device company focused on designing, 
developing, and marketing spine 
products to treat degenerative 
conditions. Fischgrund currently serves 
as professor of Orthopaedic Surgery 
at The Oakland University School 
of Medicine, at William Beaumont 
Hospital in Royal Oak, Mich. A board 
certified orthopaedic spine surgeon 
with more than 20 years of experience, 
Fischgrund has served as the Editor-in-
Chief of the Journal of the American 
Academy of Orthopaedic Surgeons 
since 2009.
STUART S. KAPLAN, M.D. ’88, G.M.E. ’89, 
was recently elected as a Fellow of the 
American College of Radiology.
1990s
STEVEN A. ROBICSEK, M.D. ’95, PH.D., 
clinical associate professor of Anesthesi-
ology, director of Medical Student Anes-
thesia Electives at University of Florida 
College of Medicine, is concluding a 
two-year RO1 grant from the National 
Institute of Neurological Disorders 
and Stroke for his research “Neuronal 
Biomarkers in Severe Traumatic Brain 
Injury.” 
MICHAEL R. YOCHELSON, M.D. ’95, was 
appointed vice president of Medical 
Affairs and Chief Medical Officer for 
the MedStar National Rehabilitation 
Network in July 2011. He also recently 
Make an Informer
Decision.
1.00%
Money Market Fund
1.95%
5-year CD
5.8%
GW Charitable Gift Annuity
(donor age: 75; requires minimum $10 ,000 gift)
Charitable Gift Annuities are not investments
Not immcdiatcl y available in II , ND or WI
To learn more about how a charitable gift annuity
is good for you and for the George Washington
University School of Medicine and Health
Sciences contact the office of Planned Giving
at 877-498-7590 or pg iv ing l(a'gwu.edu ,
or visit our wcb sitc:
go.gwu.edu/plannedgiving
s•
I'
32   smhs.gwumc.edu    •    S P R I N G  2 0 1 2
CLASS NOTES
completed his M.B.A. at the University 
of Maryland, R.H. Smith School of 
Business. Yochelson has also been recog-
nized among the “Top Docs” serving 
Northern Virginia in 2010 and 2011.
ALEX J. MECHABER, M.D., G.M.E. ’97, was 
recently appointed senior associate dean 
for Undergraduate Medical Education 
at the Miller School of Medicine at the 
University of Miami. 
2000s
JOHN YARBROUGH, M.D. ’04, M.B.A., 
joined the hospital medical staff at 
St. Joseph’s Behavioral Health Center. 
Yarbrough, received the America’s 
Top Psychiatrists Award from the 
Consumers’ Research Council of 
America twice, and has a special inter-
est in the treatment of abusive parents 
with mental illness. 
MARK J. FAVOT, M.D. ’08, will begin his 
new position as assistant clinical profes-
sor and director of Emergency Ultra-
sound at Sinai-Grace Hospital, Wayne 
State University School of Medicine, in 
July 2012. 
JENNIFER S. JACKSON, M.D. ’08, will 
complete her Emergency Medicine 
residency at Yale University School of 
Medicine/Yale-New Haven Medical 
Center in June 2012. 
FRANCES SESSLER, M.S. ’09, has been 
named the National Dean for the 
Remington College of Nursing in 
Orlando, Fla., where she is develop-
ing a new occupational therapy assis-
tant program and teaching an online 
research methods course.
ERIC M. THOMSON, M.D. ’09, was accepted 
to the Virginia Commonwealth Univer-
sity’s Fairfax Family Practice Sports 
Medicine Fellowship. 
JOSEPHINE SCHLOESSER, B.S. ’10, received 
the 2011 VISTA Award for Teamwork 
from the American College of Radiol-
ogy Imaging Network, for her work on 
the RESCUE: Randomized Evaluation 
of Patients with Stable Angina Compar-
ing Utilization of Diagnostic Examina-
tions Trial. 
In Memoriam
Alumni
PATRICK C. DIETLER JR., M.D. ’48
JOHN A. DOLAN, M.D. ’61
O. HERMAN DRESKIN, M.D. ’41
LALA M. DUNBAR, M.D., PH.D. ’78
JOHN L. FORD, M.D. ’65
GEORGE M. HENNEBERGER, M.D. ’58
MELISSA A. HYNES, M.D. ’02
JOHN E. KELLY, M.D. ’59
ROBERT L. LARSON, M.D. ’53
CLINTON J. MCGREW, M.D. ’55
ERNEST C. MCKIBBEN, M.D. ’45
JOHN G. MONYAK, M.D. ’52
MATTHEW D. PARRISH, M.D. ’50
JULIUS PIVER, M.D. ’52, 
RULON D. ROBISON, M.D. ’59
STANLEY B. ROSENDORF, M.D. ’53
JOHN L. SIDDOWAY, M.D. ’46
GEORGE A. SOLACK, M.D. ’60
CHARLES A. STUMP, M.D. ’52
CARLTON E. SWETT, M.D. ’54
NEVILLE I. THROCKMORTON, M.D. ’48
CLIFFORD L. WALKER, M.D. ’45
ELIZABETH ANN ZIMMERMAN, M.D. ’91
In Memoriam
F. ELWOOD DAVIS, J.D. ’43, died from complications from pneumonia, 
Jan. 17, 2012. He was 96 years old. A former University trustee, GW 
Presidential Medal recipient, and Chair of the Walter A. Bloedorn 
Foundation (named after a former dean of the School of Medicine and 
Health Sciences), Davis donated more than $2 million to GW and the GW 
Medical Center since the late 1970s. Davis earned his law degree at GW in 
1943 before becoming an ensign in the U.S. Navy and serving in the Pacific 
Theater during World War II. Following his service, Davis worked for Riggs 
National Bank and later co-founded the law firm of Reasoner, Davis, and 
Vinson. He was general counsel to GW and was noted for his work to gain 
home rule for Washington, D.C. In 2002, an endowment from the Davis 
family established the F. Elwood and Eleanor Davis Endowed Professorship 
at the GW Law School. Davis’ wife of 66 years, Louise Grunwell Davis, died 
in 2009. He leaves three children, Robert Davis, Anne Spratt, and Lynne 
Whitley; and six grandchildren.
New job? Publication? Change of address?
Share your news!
Please send your updates to smhsalumni@gwu.edu
or call (202) 994-7511
or visit www.gwumc.edu/alumni-update Q
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Vascular Disease 
Foundation President’s 
Award Goes to Sidawy
Anton Sidawy, M.D., M.P.H. ’99, 
professor of Surgery in the GW School 
of Medicine and Health Sciences 
(SMHS), and chair of the Department 
of Surgery at the GW Medical 
Faculty Associates, received the 
Vascular Disease Foundation’s (VDF) 
President’s Award for Leadership. 
The award was presented at the 
foundation’s eighth annual meeting in 
Washington, D.C. in September 2011. 
The President’s Award for Leadership 
honors Sidawy’s commitment to the 
foundation’s mission of increasing 
awareness of vascular disease and 
improving vascular health. 
“We are pleased that Dr. Sidawy 
has been recognized by the Vascular 
Disease Foundation for his leadership 
and commitment to improving 
awareness of vascular disease,” 
said Jeffrey S. Akman, M.D. ’81, 
G.M.E. ’85, interim vice president for 
Health Affairs and dean of SMHS. 
“As an academic and a mentor 
for the next generation of medical 
professionals, Dr. Sidawy’s efforts 
educating students, physicians, and 
the public about the risks, prevention 
and treatment of vascular disease are 
remarkable.”
In addition to his academic and 
clinical responsibilities at GW, Sidawy 
serves as the editor-in-chief of the 
Journal of Vascular Surgery and is a 
former president of the Society for 
Vascular Surgery. Sidawy has been 
a member of the board of directors 
of VDF since 2003 and served as its 
president from 2006 to 2010.  n
Exploring Molecular 
Mechanisms to Predict 
Neurological and 
Psychiatric Diseases
Anthony-Samuel LaMantia, Ph.D., 
professor in the Department of 
Pharmacology and Physiology, and 
director of the GW Institute for Neuro-
science in the School of Medicine and 
Health Sciences received a five-year, 
$1.6 million grant from the National 
Institutes of Health to identify molecu-
lar mechanisms that define embryonic 
olfactory epithelium (OE) stem cells. 
These stem cells, once established in 
the developing nose, regulate lifelong 
genesis of olfactory receptor neurons 
— the cells that mediate the sense 
of smell — and are likely pathogenic 
targets for neurological and psychi-
atric diseases, including Parkinson’s 
and Alzheimer’s diseases as well as 
schizophrenia. 
“Olfactory epithelial stem cells are 
the only neural stem cells in humans 
that constantly make new neurons 
that make new connections over a 
lifetime,” explains LaMantia. “If we 
can understand how the nervous sys-
tem establishes stem cells that can 
provide for ongoing replacement and 
repair, we will be able to create an 
outline of how one might harness the 
same mechanisms to repair parts of 
the brain that do not normally regen-
erate or recover after damage.”
Stem cells in the embryonic ver-
tebrate olfactory epithelium gener-
ate critical peripheral chemosensory 
and central neuroendocrine neurons 
essential for feeding, social interac-
tions, and reproduction. LaMantia 
and his colleagues defined these 
stem cells over the past several years. 
Nevertheless, the mechanisms for 
establishing and maintaining these 
olfactory epithelial stem cells remain 
unknown. Now, GW researchers led 
by LaMantia will define molecular 
mechanisms that are in the network 
of genes that are essential for defining 
OE stem cell identity and their abil-
ity to make the mature neurons that 
ensure ones sense of smell.
To learn more about the work of 
the GW Institute for Neuroscience, 
visit www.gwumc.edu/ 
neuroscience.  n
FACULTY NEWS
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Naomi L. C. Luban, M.D., 
professor of Pediatrics at 
GW’s School of Medicine and 
Health Sciences (SMHS), and 
division chief of Laboratory 
Medicine, Hematology, at 
Children’s National Medical 
Center (Children’s National), 
and Lori Luchtman-Jones, 
M.D., associate professor 
of Pediatrics, SMHS, and 
division chief, Hematology, 
at Children’s National, have 
secured funding from the 
National Heart, Lung, and 
Blood Institute at the National Institutes of Health (NIH) for a new pediatric 
transfusion medicine and hematology research program with the Children’s 
Research Institute at Children’s National. The program will prepare 
candidates for academic leadership and research careers.
The program, the Pediatric Hematology and Transfusion Medicine 
Multidisciplinary Research Training Award, will pair faculty and resources 
from SMHS, NIH, the American Red Cross, the U.S. Food and Drug 
Administration, and Howard University School of Medicine in an attempt 
to close a gap in the number of researchers and pediatric subspecialists in 
hematology and transfusion medicine.
The program is designed to encourage diversity among trainees and 
will draw upon the strengths of the partnering organizations, including a 
wide range of senior mentors, as well as an infrastructure to support trainee 
research from the Clinical and Translational Science Institute at Children’s 
National.  n
Congratulations to  
the 2012 “Golden 
Apple” Awardees
Congratulations to the 2012 “Golden 
Apple” awardees. The annual awards 
recognize the contributions of GW 
School of Medicine and Health Sci-
ences (SMHS) professors who have 
made a significant impact on the 
students’ education. SMHS students 
present the Golden Apples during 
the Medical School Follies, an annual 
student talent show.
Each year, first- and second-year 
medical students nominate their favor-
ite professors, while third- and fourth-
year students nominate one resident 
and one teaching faculty member. The 
awards are part of the nominating pro-
cess for the American Medical Student 
Association’s National Golden Apple 
Award for Teaching Excellence.
This year, first-year students award-
ed Ron Bohn, Ph.D., associate pro-
fessor of Anatomy and Cell Biology; 
second-year students honored David 
Diemert, M.D., associate research pro-
fessor of Microbiology, Immunology, 
and Tropical Medicine, and associate 
clinical professor of Medicine; third-
year students selected Chris Bayner, 
M.D., a third-year resident in Urology; 
and fourth-year students awarded Jim 
Scott, M.D., professor of Emergency 
Medicine, and of Health Policy, bring-
ing Scott’s Golden Apple total to 12.  n
Unique Training Program in Transfusion 
Medicine and Hematology Established
GW Pediatrician van den Anker Receives 
2012 Distinguished Researcher Award
John N. van den Anker, M.D., Ph.D., professor of Pediatrics, and of Pharma-
cology and Physiology, was named the Distinguished Researcher of the Year 
for GW during the 2012 Research Day events. The award is presented annu-
ally to honor a member of the faculty for outstanding research achievements 
as demonstrated by the quality and significance of the faculty member’s 
work and the individual’s track record of biomedical, public health, and health 
services research.  
A neonatologist and pharmacologist, van den Anker’s research centers 
on the effects of pain medication in premature infants and directs major NIH 
clinical pharmacology grants.  n 
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Donald Karcher, M.D., chair of the Department of Pathology, was chosen to 
serve as President-Elect of the Association of Pathology Chairs (APC), the 
preeminent organization of academic departments of pathology in the United 
States, Canada, and Puerto Rico.  
As President of the APC, Karcher will work closely with the leaders of the 
other major pathology organizations such as the American Board of Pathology, 
the College of American Pathologists, and the American Society for Clinical 
Pathology, as well as the Accreditation Council for Graduate Medical Educa-
tion, Liaison Committee on Medical Education, and the Association of American 
Medical Colleges. Karcher’s term as President-Elect begins in July 2012 and he 
will become President in 2014. Currently, he serves as Councilor-at-Large.
APC provides leadership and advocacy for the discipline of Pathology and 
enables academic departments to meet the demands of its three missions — 
medical education, research, and practice.  n
Karcher Named President-Elect  
of the Association of Pathology Chairs
FACULTY NEWS
Physician Advisor 
Named for the Office 
of International  
Medicine Programs
Jeffrey Berger, M.D., M.B.A., assistant 
professor of Anesthesiology and 
Critical Care Medicine, has been 
appointed physician advisor for 
the Office of International Medicine 
Programs (IMP). Berger, who also 
holds a clinical appointment at the 
GW Medical Faculty Associates, 
has played an integral part in the 
development of the anesthesia 
international residency rotation in 
Quito, Ecuador. The rotation is the 
first to be approved by the American 
Board of Anesthesia — paving the 
way for other U.S. medical schools to 
set up similar international rotations. 
Berger will work closely with IMP 
to design and implement education 
and training programs. He also will 
provide guidance and resources to 
faculty, students, staff, visitors, and 
partner institutions.  n
Medicaid provides health care coverage for more than 4 million people 
with diabetes — a disease that is often difficult for state programs 
to administer because of high patient turnover and challenges with 
screening and follow-up.
Given these circumstances, the findings of a demonstration 
program titled DC HealthConnect are particularly promising.
Richard Katz, M.D., Bloedorn Professor of Medicine at GW’s 
School of Medicine and Health Sciences, director of the Division 
of Cardiology at GW’s Medical Faculty Associates, and chair of the 
Richard B. and Lynne V. Cheney Cardiovascular Institute, supervised 
the 12-month cell phone-based research program that followed 32 
patients as a part of the Chronic Care Initiative sponsored by the D.C. 
Department of Health.
The program tested the WellDoc DiabetesManager, a software-
based medical device that uses real-time patient coaching to redefine 
conventional diabetes management for people with Type 2 diabetes.
Katz presented the results at the 2011 mHealth Summit in 
December and published his findings in the May issue of the Journal 
of Health Communications. According to the study, DiabetesManager 
reduced ER visits and hospital stays by an average of 58 percent. 
These findings demonstrate the significant impact that real-time, 
cell phone-based diabetes management can have on a Medicaid 
population.  n
New Smartphone Software Shows  
Promise for Diabetes Management
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Debra Herrmann, M.S.H.S., M.P.H., P.A.-C., assistant professor of Physician 
Assistant Studies in the GW School of Medicine and Health Sciences (SMHS), 
received the 2011 Physician Assistant Education Association (PAEA) Rising 
Star Award for her contributions in teaching, research, administration, and 
professional service in the area of Physician Assistant (P.A.) education. 
“[Herrmann] is truly deserving of the honor because of her dedication to 
the educational mission of our program and profession,” said Lisa Alexander, 
Ed.D., P.A.-C., interim chair of Physician Assistants Studies. “Her contribu-
tions to the P.A. program include revising the curriculum and directing the 
rotation for women’s health. She is also very dedicated to her students. 
Debra is truly a valued member of the SMHS faculty.” 
In addition to her academic role, Herrmann works in the emergency 
department at Virginia Hospital Center once a week, serves on the Health 
Sciences Curriculum Committee, and Washington, D.C., Mayor Vincent 
Gray, B.A. ’64, appointed her to chair the P.A. Advisory Committee to the 
D.C. Medical Board.  n
New Leadership for Health Sciences
Joseph Bocchino, Ed.D., M.B.A., 
was named interim senior associate 
dean of Health Sciences in Janu-
ary 2012. Previously he served as 
assistant professor and chair of 
GW’s School of Medicine and Health 
Sciences (SMHS) Department of 
Clinical Research and Leadership. 
He also serves as the director of 
GW’s new graduate certificate and 
Master of Science in Health Sci-
ences (MSHS) in Clinical and Trans-
lational Research program, which 
was developed in partnership with 
Children’s National Medical Center. 
This program was established and 
supported by the National Institutes 
of Health’s Clinical and Translational 
Science Award given to GW and 
Children’s National.
Bocchino has served as an executive in the pharmaceutical and health 
care industries, as well as in the public and private sectors. His corporate 
experiences have included: hospital assignments; both domestic markets 
and global market assignments; responsibilities in pharmaceutical 
clinical research, manufacturing and marketing environments; medical 
device development and manufacturing; and oversight responsibilities for 
regulatory affairs and product registrations.  n
Health Sciences’ Rising Star 
continued from page 28
This year, John and Katherine 
generously made a half-million dollar 
bequest to SMHS, becoming even more 
deeply enmeshed in the fabric of GW. 
They have also become members of the 
University’s Heritage Society, which is a 
select group of alumni, friends, faculty 
and staff who have supported the 
institution through significant planned 
giving contributions.
The Pans say the gift is an expres-
sion of appreciation toward an institu-
tion that has been such a significant 
part of both their professional and 
personal lives. 
“Our social circles and many of our 
friends have been from GW because of 
John’s practice here,” explains Kather-
ine. “We’ve been a part of GW through-
out our professional lives.”
While the Pans didn’t specify a 
goal for their gift, they do hope it will 
support the principles behind Integra-
tive Health. 
To learn more about the Integrative 
Medicine Track Program at GW SMHS, 
visit: www.gwumc.edu/ 
trackprogram.  n
FACULTY NEWS
he George Washington University 
School of Medicine and Health Sci-
ences is forging a dynamic vision for 
the future. We aim to achieve new 
heights of excellence in fulfilling our mission of 
education, research, and patient care. In leverag-
ing the strengths of our close partnerships with 
the George Washington Medical Faculty As-
sociates and the George Washington University 
Hospital, we have the elements to attain broader 
recognition as a great academic medical center.  
One fact is clear in surveying the most 
outstanding academic medical centers across the 
country: every great institution has great philan-
thropy. Tuition revenue, insurance reimburse-
ments, and contracts alone will not generate 
the resources required to achieve excellence. 
Philanthropy provides the needed funds to sup-
port breakthrough research, cutting edge clinical 
care, and the most modern methods of medical 
and health science education. 
For that reason, the philanthropic support 
of our alumni, grateful patients, and friends has 
never had more importance or direct impact on 
our mission. For example, contributions that 
create endowed professorships allow us to retain 
and recruit leading physician-scientists and 
educators for our faculty. Donations to establish 
funds that drive biomedical research, clinical 
enhancement, technology, and scholarships 
will heighten the trajectory of GW’s growth. 
Donations to existing funds that support these 
purposes help us in a similar manner. These 
examples are a few of the main elements for our 
development efforts now and in the years ahead. 
We invite you to partner with us in taking 
on these ambitious new goals and in garnering 
widespread recognition for GW Medicine. We 
look forward to achieving great success with 
your help.
DENNIS NARANGO
ASSOCIATE DEAN OF THE SCHOOL OF MEDICINE 
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A Medical  
Education  
Makeover
The GW School of Medicine and Health 
Sciences (SMHS) recently established an ad hoc 
committee of the Curriculum Oversight Group, to 
review the school’s medical education curriculum, 
as well as examine the curricula of other medical 
school. Based on the committee’s feedback 
and recommendations, a new curriculum will 
be developed for SMHS and is on track to be 
implemented in fall 2014. Read More on Page 9
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